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ABSTRACT 
Nerve injuries complicate successful rehabilitation more than any other form of 
trauma because of loss of protective sensibility and tactile discrimination, denervation 
atrophy of muscles, and pain syndromes. While achieving full function and organ 
reinnervation after peripheral nerve injury is a challenge, a promising method of improving 
the rate and success of regeneration is the bioartificial nerve graft (BNG). The BNG 
developed in the laboratory consists of a porous bioresorbable tube containing cultured 
Schwann cells that help to direct and support nerve regeneration when used to bridge the gap 
between the ends of the severed nerve. 
To aid in the design of the BNG, a simple reaction and diffusion model has been 
developed to describe the transport and uptake of nutrients by cells in the graft. 
Implementation of the model has required experimental determination of several key 
parameters including nutrient diffusivities as a function of polymer porosity with and without 
the presence of Schwann cells, nutrient consumption rates, and productivity of nerve growth 
factor, a potent stimulator of regeneration. 
Conduits were created with varying porosities and wall thickness. Also, the effect of 
Schwann cell seeding density was evaluated. The ability of this bioartificial nerve graft to 
enhance the growth rate of neurons was then tested in vitro using dorsal root ganglia as the 
source of neurons. Growth was hindered in conduits with greater wall thicknesses and lower 
porosities. The computer model suggests that this is due to lack of oxygen within the lumen 
of the conduit. Maximum growth occurred at 75% porosity due to optimization of oxygen 
and nerve growth factor available to the axons. Reduction in growth for porosities above 
X 
75% is due to increased flux of growth factors out of the conduit. Higher Schwann cell 
seeding density enhances growth due to increased trophic support but leads to severe 
branching in both two- and three-dimensional systems. 
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INTRODUCTION 
General 
With the rising cost of health care and an insufficient number of organ donors, 
alternatives are needed to replace tissue lost to injury or disease. Three general strategies for 
creating new tissue are using isolated cells or cell substitutes, using tissue inducing substrates 
and using cells grown on or within matrices [1]. These strategies are especially applicable to 
neurodegenerative diseases and nerve injuries. Nerve cells isolated from fetal tissue have 
been shown to be effective in the treatment of Parkinson's disease, a disease caused by the 
degeneration of dopamine producing neurons in the substantia nigra of the brain [2]. Severed 
nerves can be regenerated through the use of an artificial nerve graft, a synthetic conduit that 
guides the regenerating neurons. Also, growth of neurons can lead to the creation of neuron-
based biosensors and simple neural circuits [3]. 
Statement of Problem 
The alternatives for the repair of severed nerves are suturing the severed ends 
together, bridging the gap with an autograft or allograft, or regenerating the axons through an 
artificial nerve graft. Suturing the nerve ends is only effective over short distances. 
Autografts and allografts require the use of neural tissue from the patient or a donor. Because 
autografts lead to denervation and donors are needed for allografts, the artificial nerve graft is 
a better alternative. One major drawback of the artificial nerve graft is its inability to 
regenerate axons over gaps of 1 cm or more. A means to overcome this obstacle is to seed 
the artificial nerve graft with Schwann cells which aid in the regeneration of neurons. Such a 
nerve graft needs to be designed to ensure the axons and Schwann cells receive enough 
nutrients while providing enough trophic factors to maximize the growth of the regenerating 
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neurons. 
Approach to the Problem 
The goal of this work was to design an artificial nerve graft seeded with Schwann 
cells. The basic design of the bioartificial nerve graft consisted of a porous cylindrical 
conduit seeded with Schwann cells. Parameters important to the design were assessed and a 
computer model was used to describe the diffusion and kinetics of nutrients and trophic 
factors within the conduit. Experiments were conducted to determine the diffusion and 
kinetic constants. The model was used to determine the porosities and wall thicknesses 
where oxygen may become limiting as well as the concentration of nerve growth factor that 
would be expected in the lumen of the conduit. Optimally designed nerve grafts were 
manufactured and then tested in vitro using dorsal root ganglia for the source of neurons. 
Experimental results were then compared to model predictions. 
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BACKGROUND 
The Peripheral Nervous System 
The nervous system is divided into two sections: the central nervous system, 
comprised of the brain and spinal column, and the peripheral nervous system. The nervous 
system is made up of neurons and glial, or satellite, cells. Glial cells in the peripheral 
nervous system are Schwann cells. The purpose of neurons is to carry signals between the 
brain and the rest of the body. Schwann cells provide support for neurons by enhancing the 
speed of electrical signals and producing proteins essential to the growth of neurons. 
Neurons can be many different shapes and sizes depending on their function, but each 
neuron has a cell body, an axon, and dendrites (Figure 1). The two types of neurons found in 
the peripheral nervous system are the sensory and motor neurons. Sensory neurons carry 
signals to the spinal column and brain from specialized receptors that can detect certain 
stimuli. The brain processes the signal and then sends another signal through the motor 
neurons in response to the stimulus. Neurons are bundled together by endoneurial tissue. 
Fibroblasts surround these bundles to form the perineurium. 
An electrical signal, called the action potential, is initiated by a specialized receptor 
on a sensory organ. Within a neuron, the signal is carried from the dendrites through the 
axon by the opening and closing of ion channels. The axon is a single long process extending 
from the cell body and ending at the presynaptic terminal. The axoplasm, or axon cytoplasm, 
is normally a poor conductor of electrical signals. To compensate for this, axons are 
surrounded by an insulating layer called the myelin sheath which is formed from Schwann 
cells. In contact with axons, Schwann cells will wrap themselves around the axons 
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Figure 1. The Peripheral Nervous System. Adapted from [5], 
as many as 160 times, squeezing out their cytoplasm and leaving a thick lipid layer. The 
spaces between Schwann cells where the axon is still exposed are called the nodes of 
Ranvier. Ion channels are concentrated at these nodes and it is here that action potentials can 
be propagated. Myelination can increase the conduction velocity 6000% (2 m/s to 120 m/s) 
[4], The distance between nodes can vary from 20 ^m to 2 mm. 
The synapse is the space between the presynaptic terminal of one neuron and the 
dendrites of another. Dendrites are located around the cell body and receive signals from 
across the synapse. Signals are sent across the synapse using neurotransmitters that are 
released from vesicles at the presynaptic terminal. Neurons can make multiple contacts on 
one or more neurons and it is the organization of these contacts that determines the overall 
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function of the nervous system. 
Two distinct phenotypes exist for Schwann cells depending on their relationship with 
nearby axons. In contact with neurons, Schwann cells will begin to ensheath axons. If 
neurons have axons with diameters greater than l^im, the Schwann cells will myelinate the 
axon. When Schwann cells lose contact with neurons, by some injury to the axon, the 
Schwann cells lose their myelinating phenotype markers and begin to produce a number of 
trophic factors such as nerve growth factor. With direct contact, regenerating axons stimulate 
Schwann cells to proliferate [6]. Also, these axons induce Schwann cells to form a basal 
lamina which contains collagen, proteoglycans, and laminin. Laminin, with entactin and a 
heparan sulfate proteoglycan, has been determined to be a neurite outgrowth promoting factor 
[7]. 
Nerve Growth Factor and Receptors 
When contact with neurons is lost, Schwann cells change their genetic programming 
from producing myelin associated proteins to synthesizing growth factors such as nerve 
growth factor (NGF) [8], brain-derived neurotrophic factor (BDNF) [9], and neurotrophin-3 
(NT-3) [10]. Nerve growth factor has been shown to greatly enhance the growth of neurons 
in culture [11]. Nerve growth factor is a 160 kDa protein made up of three subunits: a,p,Y. 
The p subunit is the only biologically active part of NGF [12]. The proteolytic y subunit is 
important in the processing of the P subunit while the a subunit provides structural support 
[13]. 
Receptors for nerve growth factor as well as the other neurotrophic factors are found 
in the membranes of neurons. Two receptors have been found for nerve growth factor: a low 
affinity one, pTS"^*^, and a high affinity one, trkA. The pTS"^*^ receptor also binds BDNF 
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and NT-3 with equal affinity. High affinity receptors, trkB and trkC, also exist for BDNF and 
NT-3, respectively. The p75'^°'^ receptor enhances the binding of NGF to trkA [14] and 
both collaborate to activate local signaling events [15]. TrkA has been shown to undergo 
retrograde transport when bound to NGF [16]. As a result, it has been theorized that the entire 
pTSNC^-trkA-NGF complex is taken into the neuron by endocytosis and transported toward 
the nucleus where genes become activated that elicit a morphological change leading to 
growth cone formation and axon extension [17]. 
Nerve Regeneration 
Seddon describes three different classifications for nerve injuries: neurapraxia, 
axonotmesis, and neurotmesis [18]. Neurapraxia is a blocking of the electrical signal without 
any degeneration of the nerve. Axonotmesis describes an injury that leaves the nerve trunk 
intact but leads to degeneration of the axon. Neurotmesis is the complete disruption of the 
nerve. Recovery from nerve injuries can take a few days for neurapraxia to several months 
for axonotmesis. With neurotmesis, recovery depends on the severity of the disruption. 
Axonotmesis and neurotmesis lead to the degeneration of the axon distal from the cell body 
and the eventual regeneration of new axons. 
Following axotomy, there is an acute inflammatory response and Wallerian 
degeneration begins in the distal axon. Wallerian degeneration describes the changes that 
occur physically and biochemically at the injury site. The neuron sprouts growth cones in the 
proximal end and begins to regenerate. If the neuron cannot form new synapses, it will 
atrophy or die. 
During Wallerian degeneration, Schwann cells in the distal section dedifferentiate and 
begin to proliferate. Schwann cells and macrophages phagocytize the axon and myelin 
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fragments. The neuron swells and nisi substance, the ordered arrays of endoplasmic 
reticulum, disperses away from the cell nucleus. Nerve growth factor, produced by the 
proliferating Schwann cells, acts as a chemoattractant for ingrowing axons [19]. 
Neurons sprout growth cones from their proximal stumps. The growth cone senses 
the extracellular environment and determines the rate and direction of nerve growth [20]. 
Schwann cells move cocurrently with the growth cones toward the distal segment. Once the 
growth cones reach the distal segment, they enter the endoneurial tubes left from the 
degenerated axons. The growth cones may eventually reach their targets and form new 
contacts. 
The Central Nervous System 
The central nervous system is made up of the brain and spinal column. Though 
neurons may be morphologically different, they behave similarly to peripheral nervous 
system neurons. There are two main types of glial cells in the central nervous system: 
astrocytes and oligodendrocytes. Astrocytes surround both capillaries and neurons. 
Oligodendrocytes behave like Schwann cells in that they ensheath and myelinate axons but, 
unlike Schwann cells, they inhibit neurite outgrowth [21]. Schwann cells have been found to 
reverse this inhibitory effect. When placed in the central nervous system, Schwann cells have 
been shown to enhance nerve regeneration [22]. Grafts of peripheral nerve lacking Schwann 
cells do not support CNS regeneration [23]. 
Artiflcial Nerve Grafts 
Several options exist for the repair of severed nerves: suturing the severed ends, 
suturing an allograft or autograft, or regenerating the nerve through a biological or synthetic 
conduit. Suturing the severed nerve ends can only be done for very short gaps and, even 
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then, the axons may become disorganized or entangled, forming neuromas [24]. With an 
allograft or autograft, another nerve piece is sutured to the two ends of the severed nerve in 
order to bridge the gap. This method requires the use of a nerve from a donor or from the 
patient. Synthetic conduits, or artificial nerve grafts, are now being developed to enhance the 
natural regenerative abilities of severed nerves over larger gaps. 
Tubulization, or the use of conduits for nerve repair, has been used for over a hundred 
years. The first successful nerve grafts were performed by Van Lair [25] using decalcified 
bone drains and by Von Biingner [26] using an artery. Through the years, scientists have 
tried other materials, such as stainless steel, silicone, and various polymers, in their attempts 
to improve the regeneration of the severed nerve. The advent of biodegradable polymers has 
eliminated the need for a second surgery to remove the conduit once the nerve has 
regenerated. Table 1 summarizes the variety of materials used for tubulization. Current 
research incorporates physical and chemical adjuncts to improve the regeneration of the 
severed nerve. 
Artificial nerve grafts have several advantages over suturing and using biological 
nerve grafts. The conduit insulates and protects the nerve and prevents the invasion of 
connective tissue that can lead to scarring. Growth and trophic factors are concentrated 
within the lumen of the ANG. The tube aids in the guidance of the growing nerve fibers thus 
preventing neuroma formation, or severe axon branching. Once connected to the nerve 
stumps, the conduit will prevent their dislocation or rotation. Besides enhancing nerve 
growth, the artificial nerve graft can also be used as an experimental model to study various 
aspects of nerve regeneration. Chemical factors can be extracted from the graft interior. 
Also, adjuncts can be incorporated into the conduit and their effects include lack of 
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Table 1. Materials used in Nerve Grafts 
Material Date Source 
Artery 1891-1941 [26],[27] 
Bone 1880-1915 [25],[28] 
Vein 1891-1984 [26],[29] 
Glass 1988 [30] 
Silicone 1955-Present [31],[32] 
Stainless Steel 1977-1985 [33],[34] 
Polymers: 1955-Present 
Polyvinylchloride [35] 
Polytetrafluoroethylene [36] 
Polyethylene [37] 
Biodegradable Polymers: 1982-Present 
Poly-lactic acid/PCL [38] 
Poly-glycolic acid [39] 
Poly-glactin [40] 
dimensional stability, especially in bioresorbable conduits, and fibrosis. 
Conduits have been made from various synthetic materials. An ideal material for use 
in artificial nerve graft should be biocompatible and bioresorbable. The degradation rate of 
the material should be low so that the conduit keeps its shape and strength throughout the 
time of regeneration. If possible, the material should inhibit processes causing nerve 
pathology while promoting processes that enhance nerve growth. 
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The design of the artificial nerve graft will significantly affect the extent and success 
of nerve regeneration. Conduits may constrict the growth of axons if the inner diameter is 
too small. The optimal inner cross-sectional area for non-degradable conduits has been 
determined to be 2.5-3 times that of the nerve bundle [41]. Constriction in bioresorbable 
conduits is not a problem unless swelling of the polymer decreases the inner diameter. The 
wall thickness of the conduit may also affect regeneration since neuroma formation was 
found to decrease in Silastic tubes with thinner walls [41]. Conduits with pores have allowed 
more axons to bridge the gap than without [42]. The exchange of nutrients between the 
lumen and the outer environment has been shown to enhance nerve growth especially in the 
absence of the distal nerve stump [43]. 
Regeneration within the conduit occurs in a manner similar to normal regeneration 
(Figure 2). Following injury, fluid accumulates within the lumen of the conduit. The distal 
nerve stump undergoes Wallerian degeneration. Trophic factors are concentrated within the 
conduit. Fibroblasts migrate into the gap to form a fibrin bridge and will eventually form a 
new perineurium. The fibrin bridge acts as a support structure for the regenerating axons. 
The axons migrate concurrently with Schwann cells across the gap. Once the axons reach the 
distal stump, ihey enter the endoneurial tubes which act to guide the neurons to their target. 
There they will eventually form new synaptic connections. 
Four different mechanisms have been theorized to govern regeneration within an 
artificial nerve graft [44]. Operative alignment states that axon destination is determined by 
its physical alignment at the site of repair. Contact guidance describes axons recognizing a 
specific substrate along a particular path [45]. With neurotropism, the direction of axons is 
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Figure 2. Nerve Regeneration in an Artificial Nerve Graft. Following injury, fluid 
accumulates within the conduit lumen and the distal stump undergoes Wallerian degeneration. 
Fibroblasts migrate across the gap forming a fibrin bridge. Schwann cells and axons co-
migrate over the bridge and eventually enter the distal stump and form new synapses. 
determined by a chemical gradient of agents diffusing from the distal stump [44]. In 
neurotrophism, axons grow along random paths but will receive support when the appropriate 
contact has been reached [46], Though each of these mechanisms have been demonstrated in 
experiments, the extent to which each mechanism is important remains controversial and may 
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depend on the type of neuron. 
Besides the conduit itself, physical and chemical adjuncts can be incorporated to 
influence the mechanisms of nerve regeneration. A variety of substances such as agar and 
gelatin have been added to the lumen of the conduit but were found to be ineffective because 
they interfered with the formation of the fibrin bridge that connects the nerve stumps [47]. 
To simulate this fibrin bridge, nylons fibers have been used [48]. A multiple lumen cuff may 
also be used to keep axons aligned with their target [49]. Neurons will preferentially grow on 
surfaces containing laminin, a protein found in the basal lamina of Schwann cells [SO]. 
Weiss has concluded that "the ideal substratum for nerve regeneration is degenerated 
peripheral" nerve [47]. Several growth factors can be added to the artificial nerve graft to 
influence regeneration. Nerve growth factor released from degrading polymer conduit is 
effective in enhancing the growth of axons [51]. Both acidic and basic fibroblast growth 
factors enhance the regeneration of axons though the exact mechanism is unclear [52],[53]. 
While other growth factors, such as brain-derived neurotrophic factor, insulin-like growth 
factors, ciliary neurotrophic factor, and transforming growth factor beta have a role in axon 
survival and repair, their effects on regeneration within a conduit have yet to be established 
[44]. 
Use of Schwann Cells in Artificial Nerve Grafts 
Because Schwann cells are known to enhance the regeneration of axons, not only in 
the peripheral nervous system but also in the central nervous system, they make an attractive 
addition to artificial nerve grafts. This bioartificial nerve graft was first used by Guenard, et 
al. in 1992 to enhance regeneration in the peripheral nervous system [54]. A graft made of a 
copolymer of poly-acrylonitrile and poly-vinyl chloride contained Schwann cells suspended 
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in Matrigel within the lumen of 1 cm conduit. The conduit was highly porous but had a 
molecular weight cutoff of 50,000, low enough to retain neurotrophic factors within the graft. 
The graft was used to regenerate sciatic nerve over an 8 mm gap over a three week time 
period. The suspended Schwann cells formed a cable that enhanced regeneration depending 
on the cell density. The number of axons that were myelinated also increased in a Schwann 
cell density dependent fashion. The Schwann cells also helped the axons overcome the 
blocking effect that is associated with Matrigel. This same conduit was also shown to 
promote regeneration in the spinal cord [55]. 
Schwann cells were also being used to overcome the 1 cm gap barrier over which 
conduits have not been successful in regenerating axons. Schwann cells suspended in gelatin 
within the lumen of poly-glycolic acid conduits did not appear to enhance regeneration over a 
3 cm gap [56]. The Schwann cells may not have survived in this model. On the other hand, 
Schwann cells forming a monolayer on the inner wall of a polyethylene conduit permitted the 
regeneration of axons over a 2 cm gap [57]. In this case, axons regenerated over the 2 cm 
gap after about 8 weeks compared to no regeneration seen in the control containing no 
Schwann cells. Besides synthetic polymers, collagen guides can also serve as support for 
Schwann cells in a bioartificial nerve graft [58]. Functional recovery occurred sooner in 
conduits seeded with more Schwann cells. The addition of Schwann cells allowed 
regeneration over an 18 mm gap. No recovery was seen in the control groups not seeded with 
Schwann cells. Conduits are also being developed that combine several regeneration 
enhancements. Hadlock, et al have created a nerve graft made from a nonporous 
biocompatible bioresorbable polymer and containing Schwann cells on the surface of 
multiple lumens [59]. The multiple lumens provide greater surface area for cell attachment 
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as well as improved guidance of nerve fascicles. 
While some work has been done to examine the effects of Schwann cells on 
regeneration through conduits, additional information is needed on the physical design of the 
conduit and how it influences axon growth as well as Schwann cell functionality. Enough 
nutrients need to be supplied to the Schwann cells and axons to ensure their survival. Also, 
the physical dimensions, porosity, diameter and wall thickness of the conduit need to be 
optimized with respect to the regeneration of the axons. A computer model, one of the aims 
of this project, was developed to describe uptake of nutrients and trophic factors by the 
Schwann cells and axons. The model was then used to determine the physical characteristics 
of the conduit that maximizes axon growth while supplying the required nutrients to the cells. 
Such a model should help reduce the number of experimental studies, in vitro and in vivo, 
necessary to test the bioartificial nerve graft. 
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MATERIALS AND METHODS 
Overview-Design of the Bioartiflcial Nerve Graft 
Artificial nerve grafts have successfully been used to enhance the regeneration of 
peripheral nerve. Because Schwann cells produce neurotrophic factors, such as nerve growth 
factor, they can enhance regeneration within the nerve graft. To ensure that the Schwann 
cells, as well as the axons, are getting enough nutrients to survive in the graft, adequate 
nutrients must be supplied. Since the cells will receive nutrients from the bulk fluid, it is 
necessary to characterize both the diffusive properties of the nutrients as well as the 
consumption rates of the nutrients to determine an acceptable size range for the conduit. The 
conduit itself should be made of a bioresorbable material to eliminate the need for later 
removal and should be able to keep its shape until the regeneration is complete. 
In this work, the bioartiflcial nerve graft (BNG) is comprised of a poly-D,L-lactide 
tubular conduit seeded with Schwann cells (Figure 3). PDLLA was chosen for its 
biocompatibility and bioresorbability. Also, the degradation rate is low enough so that the 
conduit will remain intact for up to 7 months, the time it can take for an adult human to fully 
recover a nerve injury. The Schwann cells form a layer on the inner surface of the conduit 
and produce nerve growth factor that enhances the regeneration of axons within the lumen of 
the conduit. The Schwann cells will proliferate and migrate into the lumen of the conduit to 
further enhance regeneration. 
Theoretical Model of Transport and Reaction in the BNG 
A simple model has been developed to describe diffusion and kinetics of NGF, 
oxygen and glucose within the conduit. NGF has been shown to greatly affect the growth of 
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Figure 3. Design Schematic of the Bioartificial Nerve Graft. Schwann ceils form a layer on 
inner surface of the conduit (blue) and produce NGF that will diffuse into the lumen and out 
into the bulk. The model describes mass transport from the bulk, through the conduit wall 
and Schwann cell layer, and into the nerve tissue in the lumen. 
axons. Oxygen and glucose are nutrients that are important to the survival of cells and may 
become limiting in the nerve graft. Cylindrical layers represent the various regions of the 
BNG. These layers, from the center outward, are the axons, the Schwann cell layer, the 
conduit wall, and the surrounding fluid or tissue. Nutrients will be supplied to the conduit by 
bulk fluid in vitro or by blood vessels in vivo. Nerve growth factor will be produced in the 
Schwann cell layer and will diffuse into the lumen or out to the bulk. The NGF in the lumen 
will be consumed by the neurons as they regenerate. 
This system can be described by a reaction-diffusion model in four concentric 
cylinders. Assuming that diffusion is only significant in the radial direction, the microscopic 
mass balance can be simplified to; 
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r 
0 = D. 
where: 
r dr 
i = layer 
dC.. ij 
dr 
+ R. ( 1 )  
/J 
j = component 
Dij = diffusion constant (cmVs) 
Rij = Kinetic Rate (mg/ml • s) 
Cij = Concentration (mg/ml) 
with boundary conditions of 
Flux: Nij (@R=0) = 0 
Fluxes at the layer interfaces are equal, giving 
Flux at outer surface: Ny = k(Cs-Cbuik) 
Cjj (R->o<') = Cbulk 
Mass transfer is assumed to occur at steady state. An order of magnitude analysis was 
done check this assumption. Estimates were made for the unsteady state form of equation 
(1). The analysis (See Appendix D) shows that the time dependent term is at least two orders 
of magnitude lower than any other term. For this system, the steady state assumption is valid. 
While diffusion occurs in all four layers, reactions only take place in the Schwann cell 
and axon layers. A mass transfer coefficient (cm"') is used to describe transport through the 
boundary layer on the outer surface of the conduit and can be adjusted depending on whether 
regeneration through the graft occurs in vitro or in vivo. The diffusion coefficients and rate 
constants must be determined experimentally. 
NGF interacts with two different receptors on the surface of neurons before being 
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taken into the cell by endocytosis [17] (Figure 4). A reaction mechanism has been developed 
for this system. Using the equilibrium assumption, the rate law becomes (See Appendix C for 
details); 
{KHoLo)S 
{ K „ + S t K , + S )  
This rate expression is inserted into the model to account for the consumption of NGF 
by the axons. 
Besides the kinetic and diffusion parameters, the Schwann cell and neuron densities 
were also determined. The rate (R,j) is a product of the density (cells/ml) and the specific 
K, H 
Retrograde 
Transport 
S + H 
S + L 
K, 
SH + L k 
SL + H '^ 2 
SHL 
» - Nerve Growth Factoi(S) 
E - p75NGFR(L) 
a -trkA(H) 
Figure 4. Dual Receptor Model for NGF Uptake. NGF can bind to a low affinity 
(p75NGFR) Qj. affmity (trkA) receptor. Once bound to both receptors the entire 
complex is taken into the cell by endocytosis. The mechanism (upper right) describes 
this situation 
19 
production or uptake rate (mg/cell • s). The axon density was based on the number of axons 
found in the rat sciatic nerve. The number of Schwann cells was estimated assuming the 
cells form a monolayer on the walls of the pores and that the pores are straight and 
cylindrical. In this design, the Schwann cells can migrate into the pores to form a thick layer 
within the inner surface of the conduit. With the parameters set, a computer program was 
written in FORTRAN to solve the differential equations. The equations were solved by the 
fourth order Runge-Kutta method using NAG subroutines incorporated into the program. 
The following paragraphs describe the experimental work that was done to 
characterize reaction and transport in the BNG followed by development and testing of the 
BNG. Briefly, the parameters determined from the characterization experiments were used in 
the theoretical model, which was used to help design the conduit. The conduits were then 
made and tested for their ability to support nerve regeneration in vitro. 
Schwann Cell Cultures 
Schwann cells were obtained using the method developed by Morrisey in 1991 [60]. 
Sprague-Dawley rats, 16-20 days old, were anesthetized by placing them in a sealed chamber 
with approximately I ml ethyl ether (Fisher Scientific, Itasca, IL) and then decapitated. A 
small incision was made through the skin near the base of the tail. The skin was cut back 
revealing muscle tissue by the hind limbs. The muscle tissue near the hind limbs was 
separated using forceps to provide access to the sciatic nerve. The sciatic nerve was removed 
and kept in chilled Gey's Balance Salt Solution (Gibco, Gaithersburg, MD) supplemented 
with 6.5 mg/ml glucose (Sigma, St. Louis, MO). The epineurium, connective tissue, and 
blood vessels were removed using fine forceps and the nerve was cut into pieces 
approximately 1 mm in length. 
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The nerve pieces were placed in 60 mm tissue culture plates (Fisher Scientific). 
Chicken plasma (Sigma) was first dissolved in sterile water (30 mg/ml). Approximately 75 ^il 
of the solution was spread evenly over the bottom of the plate. Nerve pieces were placed in 
the dish spaced 8 mm apart. Each dish contained approximately 30 nerve pieces. One 
hundred microliters of thrombin (2 units/ml) (Sigma) were added to the plate and mixed with 
the chicken plasma. Fibrin from the chicken plasma was allowed to clot for about five 
minutes before adding 3.2 ml medium. The medium used for the cell cultures was 
Dulbecco's Modified Eagles Medium, DMEM, (Gibco) with 10% v/v fetal bovine serum, 
FBS (Gibco or Sigma) and 0.02 mg/ml gentamycin (Sigma). 
The medium was changed every two days. As the nerve pieces began to degenerate, 
fibroblasts would begin to spread onto the plate. When enough fibroblasts spread onto the 
plate, over a period of 5-7 days, the nerve pieces were transplanted onto new tissue culture 
plates using the above procedure. 
After 3 or 4 transplantations, the cells spreading from the nerve pieces consisted 
mostly of Schwann cells. At this point the nerve pieces were dissociated. The nerve pieces 
were removed from the dishes and placed in 15 ml centrifuge tube (Fisher Scientific) 
containing 5.0 ml of Hank's Balanced Salt Solution (HBSS, Gibco). The nerve pieces were 
washed 2-3 times by letting the pieces setde and replacing the HBSS. After the final 
washing, 5.0 ml of HBSS containing 0.25% w/v trypsin (Sigma) and 250 units/ml 
collagenase (Worthington Biochemicals, Lakewood, NJ) were added to the centrifuge tube. 
The nerve pieces were then incubated for one hour at 37°C. The HBSS was removed and the 
nerve pieces were washed once as above for five minutes and the waste was removed. Five 
milliliters of fresh HBSS and 100 pJ trypsin inhibitor (Sigma) were added to the tube and the 
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tube was allowed to sit for 5 minutes before removing the fluid. The nerve pieces were 
washed once and as much HBSS as possible was removed. One milliliter DMEM/10%FBS 
was added to the tube and the tissue was triturated using a 1 ml sterile pipette (Fisher 
Scientific). The cell suspension was centrifuged for 10 min at 93xg. The medium and cell 
debris were removed and the remaining cells were resuspended in 1 ml of fresh medium. The 
cell suspension was placed in 75 cm" tissue culture flask (Fisher Scientific) and enough 
medium was added to make 10 ml. 
Two different methods were used to purify the Schwann cell cultures. The first 
method, modified from the procedure used by Brockes in 1979 [61], was used for the initial 
oxygen and glucose uptake rate experiments. The medium was removed from a flask 
containing Schwann cells. The cells were washed with 10 ml of HBSS for 10 minutes. Ten 
milliliters HBSS with 0.25% w/v trypsin was added to the flask and allowed to sit for 1 
minute to let the trypsin soak into the cell membranes. The excess fluid was removed and the 
cells were incubated for 10 min at 37°C. The cells were checked for detachment and 10 ml 
DMEM/10%FBS was added to the flask. The cell suspension was placed into a 15 ml 
centrifuge tube and centrifuged for 8 minutes at 166xg. The supernatant was removed and 
2.0 ml of filtered anti-Thy 1.1 medium was added to the centrifuge tube. Anti-Thy 1.1 
medium was derived from TIB-103 hybridomas (ATCC, Manassas, VA) which were also fed 
with DMEM/10%FBS. Anti-Thy 1.1 was used to remove any fibroblasts present in the 
Schwann cell culture. The Schwann cells were vortexed and incubated for 30 min at 37°C. 
The cell suspension was centrifuged again for 8 minutes at 166xg and the supernatant was 
removed. Three milliliters of filtered rabbit sera complement (Sigma) was added to the 
centrifuge tube to kill the fibroblasts marked with anti-Thy 1.1. The cells were vortexed. 
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incubated for 30 min at 7>TC, and then centrifuged for 8 minutes at 166xg. The supernatant 
was removed and the cells were resuspended in 3 mi DMEM/10%FBS. The cells were 
transferred to a new tissue culture flask and 7 ml of medium were added. 
The second method for purification was derived from the work of Rutkowski in 1995 
[62]. This method replaced the procedure from Brockes. Recombinant human glial growth 
factor was used to enhance the growth rate of the Schwann cells. With the Schwann cells 
proliferating at a faster rate than the fibroblasts, purification was obtained after a few 
passages. This method eliminates the need for anti-Thy 1.1, which can reduce the number of 
Schwann cells as well as remove fibroblasts. The cells were fed with DMEM/10% FBS 
supplemented with 0.5 ^iM isobutylmethylxanthine, IBMX (Sigma), 5 mM forskolin (Sigma), 
and 25 ^g/ml recombinant human glial growth factor H, rhGGF2 (gift from Cambridge 
Neuroscience, Cambridge, MA). The half-maximal concentration for the rhGGF2 was 5 
ng/ml. This combination reduced the growth of fibroblasts while greatly enhancing the 
growth rate of the Schwann cells. 
Schwann cells were allowed to grow to confluence before being subcultured. A flask 
of cells was trypsinized using the procedure above and subcultured into three new flasks. 
Cells were not passaged more than 2 times because subculturing the cells more than twice 
leads to immortalization of Schwann cells [63]. 
Neuron Cultures 
Sprague-Dawley rat pups, 1-4 days old, were anesthetized using ethyl ether and then 
decapitated. An incision was made near the bottom of the spine. The skin was cut back 
revealing the spinal column and surrounding muscle. Long incisions were made on both 
sides of vertebrae along the length of the spine. The spine was severed near the base of the 
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neck. Using small surgical scissors, individual vertebrae were snipped and pulled back 
revealing the spinal column. The spinal column was removed to provide access to the dorsal 
root ganglia (DRG). DRGs were removed with fine forceps and placed in chilled GBSS. 
The surrounding tissue was stripped from the DRGs using fine forceps. 
For some experiments, the dorsal root ganglia were dissociated. These DRGs were 
transferred to a 15 ml centrifuge tube and then washed once for 5 minutes in 5 ml HBSS. 
The fluid was removed and 5 mL of HBSS containing 0.1 % w/v trypsin and 0.1 % w/v 
collagenase were added. The cells were incubated for 45 minutes at 37''C and then 
centrifuged for 10 minutes at 166xg. The supernatant was removed and the cells were 
resuspended in 5 mL of HBSS with 0.25% w/v trypsin. The DRGs were incubated for 10 
minutes at 37°C and centrifuged again for 10 minutes at 166xg. The supernatant was 
removed and replaced with 5 mL of DMEM/10%FBS to inhibit enzyme activity. Cells were 
triturated using a series of progressively narrower Pasteur pipettes (Fisher Scientific). The 
cell suspension was placed in tissue culture flasks or dishes depending on the experiment. 
Once the cells were attached, the medium was replaced with DMEM/10%FBS supplemented 
with 5 loM cytosine-P-arabinoside to prevent the proliferation of fibroblasts and Schwann 
cells. 
Determination of Cell Numbers 
Schwann cell numbers were determined by trypan blue exclusion using a 
hemacytometer (Fisher Scientific) while neurons were counted using image analysis. 
Schwann cells were trypsinized and placed in a centrifuge tube. The cells were centrifuged 
for 10 minutes at 166xg and then resuspended in approximately 3 ml of HBSS. Two hundred 
microliters of cell suspension were placed in a vial with 200 of fresh HBSS and 100 |il of 
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trypan blue (Sigma). A sample of the resulting cell suspension was placed on the 
hemacytometer. Viable and nonviable cells were counted in the center and four comer grids 
of both sides of the hemacytometer (10 total). Counts were done in triplicate and averages 
for total cell numbers and viability were calculated. 
Because of the small numbers of neurons used in experiments and the fact that the 
cultures also contained fibroblasts and Schwann cells, using a hemacytometer was not always 
a viable method for determining cell counts. Instead the neurons were counted using image 
analysis. NeuroTag Red (Boehringer Mannheim, Mannheim, Germany) was used to stain the 
neurons. The tissue culture dishes were washed 3 times for 5 minutes with 1.0 ml of 10 mM 
phosphate buffered saline, PBS (Sigma). The NeuroTag Red was diluted to 5 |ig/ml in PBS 
containing 0.1% w/v bovine serum albumin, BSA (Sigma). PBS was removed from the 
dishes and replaced with 0.5 ml of the NeuroTag Red solution. The dishes were incubated 
for 2 hours at 37°C. Images were taken at several random points on the dish using a camera 
(Olympus, Melville, NY) loaded with 200 ASA color slide film (Kodak, Rochester, NY) 
attached to a fluorescence light microscope (Olympus). The excitation and barrier filters 
used with this microscope were 545 nm and 590 nm, respectively. Images were scanned into 
a computer and analyzed using Image Pro Plus software. The software was used to reduce 
background noise and to visually separate neurons from other image artifacts based on size. 
The average number of neurons for a certain area was determined. The total number of 
neurons in culture was determined based on the area of the tissue culture dish assuming 
dissociated neurons were distributed evenly on a tissue culture dish. 
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Formation of Porous Membranes 
Circular porous membranes for the diffusion experiments were made using a 
procedure described by Mikos in 1993 [64]. Poly-D,L-lactide (gift from Purac, Lincolnshire, 
IL), MW = 280,000, was chosen for its high purity, low cytotoxicity, and slow rate of 
biodegradation. Salt was used to create the porous network in the polymer. Approximately 
16 ml chloroform (Sigma) per gram of polymer was used to dissolve the poly-D,L-lactide. 
Large crystals of sodium chloride were placed in a grinder (Fisher Scientific) and then sifted 
through a 106 p.m screen (Fisher Scientific). The smaller crystals were added to the polymer 
solution and mixed thoroughly. The amount of salt and polymer needed was determined as 
follows: 
^NaCI (3) 
M pni 1A =Ppnt 1 A(l~e)^R''h (4) 
The suspension was poured into molds (Figure 5) and the chloroform was allowed to 
evaporate. Once the polymer began to gel, about 4 hours, the mold was placed in a vacuum 
chamber to remove any residual chloroform. The membranes were removed from the mold 
and the thickness of the membrane was determined using a caliper (Fisher Scientific). The 
Figure 5. Mold for Formation of Membranes. The polymer and salt suspension is poured 
into mold and the chloroform evaporates leaving a membrane. The mold is taken apart and 
the membrane removed. 
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salt crystals were dissolved out of the membrane using water. The membranes were later 
dried and then weighed. The final porosity was estimated using the mass, thickness and 
radius of the dried membrane. 
Din'usion Experiments 
An apparatus was designed to examine the diffusion of glucose, oxygen, and NGF 
through membranes of varying porosities [65]. Figure 6 shows the basic design of the 
apparatus. The apparatus consist of two semicircular chambers separated by the membrane 
holder. Each chamber has a volume of 33 ml and contains a magnetic stir bar. The 
membrane was placed between rubber and metal gaskets within the holder. The metal 
gaskets were either 2.25 cm or 3.0 cm in diameter. The membrane holder was also placed 
between rubber gaskets to seal off the two chambers. Vacuum grease was applied when 
necessary to further seal the apparatus. 
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Figure 6. Apparatus used for Diffusion Experiments. Two chambers are separated by a 
porous membrane. Ports can be used for sampling or insertion of oxygen probes. Inlets and 
outlets are included for the circulation of fluid. 
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The diffusion data were analyzed using a modification of Cussler's solution [66] (See 
Appendix B for details). Assuming the substrate forms a linear concentration gradient 
through the membrane and that the ratio of membrane volume to chamber volume is much 
less than 0.1, diffusion can be described by: 
where 
a(t) = chamber 1 solute concentration (mg/ml) 
b(t) = chamber 2 solute concentration (mg/ml) 
t = time (minutes) 
ao, bo = concentrations at time = 0 
R = exposed membrane radius (cm) 
E = porosity 
Dg = effective diffusivity (cmVs) 
L = membrane thickness (cm) 
V = chamber volume (ml) 
To determine the effective diffusivity of glucose, one chamber was filled with 33 ml 
of 13 mg/ml glucose (Sigma) in water and the other chamber with water only. The apparatus 
was placed in an incubator at 37''C. Samples were taken from each chamber once every hour 
and analyzed for glucose content. During each sampling, three 10 |il aliquots were taken 
from each chamber and diluted to 100 ^1. Triplicate 10 ^il samples from each aliquot were 
(5) 
t>(t) = -(ao +b J--(ao -bo)exp '-2jiR^eDet' 
'—10^— 
(6) 
28 
placed into a 96 well wellplate (Fisher Scientific). A glucose standard (Sigma) and blank 
were also placed in triplicate in the wellplate. At the completion of the experiment, a 
colorimetric assay was used to determine the glucose concentration. Two hundred 
microliters of Glucose Trinder solution (Sigma) was added to each well and mixed. The 
wellplate was allowed to sit for 18 minutes and then mixed again. The color change was 
detected on a microplate reader (Biotek, Winooski, VT) at a wavelength of 505 nm. 
An oxygen gradient across the membrane was made using the arrangement in Figure 
7. Oxygen microelectrodes (Microelectrodes, Inc., Londonderry, NH) were inserted through 
the top of each chamber of the diffusion apparatus. Water was recirculated between the 
chamber and a graduated cylinder. Nitrogen was bubbled through the water in one cylinder 
while air was bubbled through the other. Once the oxygen concentration in one chamber was 
close to saturation and the other was near zero, the pumps were stopped and the tubing was 
clamped effectively sealing off the chambers from the outside environment. Temperature 
02 Probes Voltmeter 
Air Inlet 
Diffusion 
Apparatus Nitrogen 
Figure 7. Schematic for Oxygen Diffusion Experiments. Water is recirculated between 
graduated cylinders and the apparatus chambers using peristaltic pumps. Nitrogen is bubbled 
through one reservoir to remove oxygen and air is pumped into the other to saturate the fluid 
with oxygen. Once the gradient has developed, the valves are closed by the ports and oxygen 
is measured with a pH/voltmeter. 
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and pressure data were gathered to determine the Henry's law constant for saturated oxygen in 
water. Readings from the microelectrodes were taken using a pH/voIt meter (Fisher 
Scientific). 
Before experimentation, the oxygen microelectrodes were calibrated using water free 
of oxygen (nitrogen purged) and water saturated with oxygen from the air. Diffusion 
experiments were run at least three times for each membrane. Several membranes of varying 
porosities were used to evaluate the effect of porosity on the effective diffusivity. A pore 
fractal model was used to describe this relationship [67]. In all fractal models, two properties 
are related in a power law relationship. In this case, the tortuosity and porosity are related by; 
T = e"'' c) 
where: 
T = tortuosity 
e = porosity 
b = power law exponent 
Diffusion through pores is described by relating an effective diffusivity, Defr to the 
tortuosity and porosity of the pores. The is relationship is shown by: 
Doff £ (8) 
Dbulk X 
Combining equations (7) and (8) gives: 
(9) 
Dbulk ^ 
Experimental data can be used to determine the power law exponent. 
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Kinetic Experiments 
Experiments were conducted to determine the uptake rate of glucose and oxygen by 
Schwann cells. For glucose uptake, Schwann cells were grown to confluence in three 75 cm" 
tissue culture flasks. The medium was removed and replaced with 4.0 ml of low glucose 
DMEM (1.0 mg/ml glucose) (Gibco) containing 10% v/v FBS and 0.02 mg/ml gentamycin. 
Twenty microliter samples were removed from each flask and diluted to 100 |J,1 with distilled 
water. The aliquots were analyzed for glucose content using the above glucose Trinder assay. 
The final volume was checked to ensure evaporative loss was negligible. At the conclusion 
of the experiment, the Schwann cells were trypsinized and counted on a hemacytometer. 
The uptake rale of oxygen by Schwann cells was determined using the apparatus 
shown in Figure 8. Schwann cells were removed from tissue culture flasks and placed into 4 
separate vials. The cells were allowed to adhere to the surface of the vials over the next 36 
hours. The medium was replaced with fresh DMEM/10% TOS. The vial was sealed with a 
rubber stopper. An oxygen microelectrode was calibrated and then inserted through a hole in 
Ports 
Oxygen Probe 
Cell Layer 
iWHWttWl 
Figure 8. Apparatus for Determining Oxygen Uptake Rate. Cells are seeded on the bottom of 
the vial. Air bubbles can be removed using syringes connected to the ports. A 
microelectrode connected to a voltmeter is used to measure oxygen content. 
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the stopper top. Syringes (Fisher Scientific) attached to two ports were used to add fresh 
medium to the vial and to remove any air pockets. Once the air was removed from the 
system, valves connected to the two ports were closed to seal the device. The entire device 
was placed in an incubator at 37°C. Readings were taken every hour from a pH/voltmeter 
and then converted to concentration. At the end of the experiment, the medium was removed 
and the volume determined using a graduated cylinder. The cells were trypsinized and then 
counted on a hemacytometer. 
This same apparatus was used to determine the nutrient uptake rates for neurons. 
DRGs were placed whole at the bottom of the vial. The DRGs were attached using the same 
clotting procedure for placing nerve pieces on tissue culture dishes. DMEM/10%FBS was 
supplemented with 5 fiM AraC to prevent the proliferation of nonneuronal cells. Oxygen 
measurements were made as with the Schwann cells. Once the oxygen experiments were 
completed, the medium was removed and the volume determined. Four milliliters of low 
glucose DMEM/10% FBS with 5 |iM AraC were then added to each vial. As with the 
Schwann cell experiments, samples were removed from each vial and analyzed using the 
glucose Trinder assay. At the end of experiment, the DRGs from each vial were dissociated 
separately and the resulting neuron cultures were placed in their own tissue culture dishes. 
The neurons were stained with NeuroTag Red and cell counts were made as described earlier. 
Nerve growth factor production by Schwann cells and consumption by neurons were 
examined under various conditions. For the consumption rate experiments, neurons from 
dissociated DRGs were placed in 25 cm" tissue culture flasks and incubated at 37° C with 5% 
CO2. The cells were fed with 5 ml of DMEM/10% FBS supplemented with 1 ng/ml NGF 
and SpM AraC. Medium samples were taken daily for five days. The NGF content was 
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determined using an enzyme-linked immunoassay (ELISA). The volume was measured after 
each sampling to account for any concentration increase that may have occurred as a result of 
evaporation. At the end of the experiment, the number of cells were determined using a 
hemacytometer. 
For the production rate experiments, 2.99x10^ Schwann cells were added to 25 cm" 
tissue culture flasks. Cell numbers were determined initially by direct counting on a 
hemacytometer. The cultures were fed with 4 ml of DMEM/10% FBS supplemented with a) 
5 |iM AraC; b) 5 rhGGF2, 5mM BMX, and 5 mM Forskolin; c) 50% v/v conditioned 
medium; d) degenerated nerve; or e) nothing. Conditioned medium is obtained from the 
medium used by neuronal cultures over 24 hours and then filtered though a sterile, 0.22 
micron filter. The conditioned medium did not contain AraC. The cells were allowed to 
grow for 48 hours before being sampled. The samples were tested with an ELISA and cells 
were removed and counted again using a hemacytometer. 
Axon Extension Rate Experiments 
The computer model was used to determine the conditions that will maximize the 
extension rate of the axons without limiting the availability of nutrients to the ceils. Because 
it was needed for the model, the effect of nerve growth factor on the extension rate of the 
axons was first evaluated at various concentrations. Because the effect of NGF on the growth 
of axons is dependent on the substratum on which the axons are growing, 24 well tissue 
culture plates (Fisher Scientific) were coated with either fibrin (Sigma) or Schwann cells or 
left blank. For the fibrin-coated plates, equal volumes, 0.5 ml, of 40 mg/ml fibrinogen and 
6.6 U/ml of thrombin in PBS were added to each well. On another set of wells, Schwann 
cells were seeded as a monolayer on the bottom of the well and then allowed to grow to 
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confluence (-8x10"* cells/cm"). 
A dilute suspension of neurons from dissociated DRGs was added to each plate. The 
cells were given 24 hours to adhere and then the medium was replaced with DMEM/10% 
FBS supplemented with 5 p.M AraC and various concentrations of 7S nerve growth factor 
(Sigma). Serial dilutions were made with NGF concentrations varying from 10 ng/ml to 1 
pg/ml by a factor of ten. 
Cultures were removed daily and stained using an immunocytochemistry kit (Dako, 
Carpinteria, CA). Briefly, cultures were fixed in 4% paraformaldehyde solution in 50 mM 
Tris buffer. Neurons were labeled using a mouse-derived antibody to neurofilament protein. 
The samples were incubated in the antibody solution for 30 min and rinsed with Tris buffer. 
Rabbit anti-mouse immunoglobulin was used as a secondary antibody. The samples were 
again incubated for 30 min. with the secondary antibody and then rinsed. Alkaline 
phosphatase and its antibody were bound to the labeled cells during a 30 min. incubation time 
period before being rinsed in Tris buffer. A naphthol substrate and Fast Red TR chromogen 
were used to stain the labeled neurons red. Mayer's hemotoxylin solution was used as a 
counterstain for the nuclei of all the cells. 
Images were taken each day for eight days using a phase contrast light microscope 
(Nikon, Melville, NY) connected to a computer to be used for image analysis. A stage 
micrometer was used to calibrate the length measurements made using the Image Pro Plus 
software package (Media Cybernetics, Silver Spring, MD). Images were taken of several 
regions of each well. The axon lengths of individual neurons were measured by image 
analysis. Care was taken to avoid clusters of overlapping neurons and neurons that may have 
contacted Schwann cells in the fibrin-coated and uncoated wells. The extension rates were 
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determined from the change in axon lengths over time. 
Conduit Formation 
The method for the production of tubular conduit was adapted from a procedure used 
by Den Dunnen in 1993 [38]. Rods were made from polyvinyl alcohol, PVA (MW= 15,000, 
ICN) using a single screw extruder (CW Brabender, South Hackensack, NJ). The 
temperature profile along the length of the screw is show in Table 2. Dies with diameters 
1/16" and 1/8" (CW Brabender) were used to produce the two sizes of PVA rods. PVA was 
chosen because of its ability to dissolve in water but not in chloroform which dissolves the 
PDLLA. The PVA rods can be dissolved slightly in water to make rods of various diameters. 
The outer diameter of the PVA rod determines the inner diameter of the PDLLA conduit. 
Table 2. Temperature Profile for Extruder 
Location 
1/16" Nozzle 
Temperature (°C) 
1/8" Nozzle 
T1 - Inlet 125 169 
T: 155 170 
T3 167 170 
T4 172 172 
Ts - Nozzle 135 142 
The rods were dip coated in a suspension of sodium chloride in poly-D,L-lactide 
dissolved in chloroform. This suspension was made in the same manner as for the formation 
of flat porous membranes. The rod was dipped into the suspension, pulled out and allowed to 
dry. The process was repeated until the desired thickness was achieved. The outer diameter 
was measured using a caliper. The rods were then cut into 1.0 cm lengths. The sections were 
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placed in water to allow the PVA and salt to dissolve. As with the flat membranes, the salt 
content can be varied to alter the porosity of the conduit. After dissolution, the sections were 
dried and then weighed in order to determine the actual porosity. Scanning electron 
microcopy images of the finished conduit are shown in Figure 9. 
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Figure 9. Scanning electron microscopy images of unseeded conduit. Left: Region of 
conduit wall cross-section shows porous structure (200x). Right: Inner lumen surface is 
relatively smooth with pores exposed (250x). 
Axon Regeneration in the Conduit 
Experiments were conducted to determine the influence of porosity, wall thickness 
and Schwann cell seeding density on the growth of axons through the conduit. Conduits 
were made with varying porosities (0.55-0.95) and wall thicknesses (0.56-1.47 mm). Once 
the conduits were dried and weighed, medical grade silicone (Dow Coming, Midland, MI) 
was used to seal one end of the conduit. The conduits were sterilized with ethylene oxide. 
The sterile conduits were placed in sterile medium under a vacuum for 10 minutes to wet the 
surface of the polymer and remove any air pockets within the pores. The medium was 
replaced everyday to eliminate any residual ethylene oxide for a period of five days. 
Schwann cells growing in culture were pooled together and resuspended in 
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DMEM/10%FBS containing 40 mg/ml fibrinogen (Sigma) to a final concentration of 2xI0' 
cells/ml. Equal volumes of the cell suspension and a solution of 200 units/ml Thrombin in 
medium were injected into the lumen of each conduit resulting in a final cell concentration of 
IxlO' cells/ml. Conduits were also prepared containing iC^, 10^, 10® cells/ml. The control 
groups were prepared in the same manner but the fibrinogen solution did not contain 
Schwann cells. The fibrin was allowed to gel for 5 minutes before the conduit was placed 
into a 24-well wellplate containing 3 ml/well of DMEM/10% FBS. Schwann cells were 
allowed to adhere to the polymer surface for 24 hours. 
Dorsal root ganglia were obtained from 6-day-old rats. One DRG was placed at the 
unsealed end of each conduit to act as a neuron source. The nerve tissue was allowed to grow 
in the conduit for four weeks before being sacrificed. Medium was changed every two days 
to prevent the build-up of nerve growth factor and replenish lost nutrients. 
At the end of the 4-week period, the conduits were removed from the wellplates and 
fixed with a solution of 4% paraformaldehyde/ 10% glutaraldehyde in DMEM. After 
fixation, the solution was removed and the conduits were rinsed with DMEM. The conduits 
were post-fixed with a 1 % solution of osmium tetroxide in DMEM for 2 hours and then 
rinsed with DMEM. The tissue was then dehydrated with a series of ethanol and water 
mixtures of increasing ethanol concentrations up to 100% ethanol. After replacing the 
ethanol three times, 15 min. each time, the tissue was placed in a 1:1 mixture of xylene to 
ethanol for 1 hour. Pure xylene was then added to prepare the tissue for paraffin embedding 
as well as to dissolve the polymer from around the tissue. The xylene was replaced every 
couple of hours until only the tissue remained. A 1:1 mixture of xylene to paraffin was added 
and the conduits were placed in an oven at 60°C for one hour. The mixture was replaced 
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with pure paraffin heated to 60°C. The paraffin was replaced three times to remove any 
remaining xylene with sufficient time to allow the paraffin to infiltrate the tissue. The tissue 
was placed in metal trays filled with excess filtered paraffin. After the paraffin was cooled 
slowly, blocks were cut from the paraffin and were prepared for sectioning on a microtome. 
Serial sections 10 |j,m thick were cut with a microtome. The sections were examined 
to determine the location of the DRG. Once located, every twentieth section was placed on a 
poly-L-lysine coated slide and allowed to dry. The slides were placed in an oven at 60°C to 
remove excess paraffin. Xylene was used to remove any remaining paraffin and the slides 
were rehydrated using decreasing concentrations of ethanol in water. Once in water, the 
slides were immersed in 0.5% solution of toluidine blue for approximately 30 seconds to 
stain the myelin sheaths of the tissue. Images were obtained for each section and analyzed to 
determine axon numbers and cross-sectional areas. A size distribution of axons along the 
length of the conduits was determined for each sample. 
Statistical Methods 
Analysis of variance was performed on the data from the neuron extension rate 
experiments and the conduit testing. Student's T-test was used to compare means and 
determine if there were any significant differences. A significance level of 0.05 was used 
forthe statistical analysis. Experiments were done at least in triplicate to ensure that adequate 
means and standard deviations could be determined. Statistical analysis was performed using 
Microsoft Excel 97. 
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RESULTS 
Diffusion Experiments 
Diffusion experiments were performed to determine the effective diffusivities of 
oxygen, glucose, and nerve growth factor through the various layers of the conduit. The bulk 
diffusivities for glucose and oxygen were obtained from literature [68], and were adjusted 
with respect to temperature. The diffusivity of NGF was estimated from literature values for 
similariy sized proteins [69]. Because the Schwann cell and axon layers consisted mostly of 
cells, diffusion in these regions was assumed to be similar to diffusion through tissue. Values 
for diffusion of oxygen and glucose through tissue were determined using a correlation based 
on the molecular weight of the diffusing species [70]. The diffusivity of NGF in tissue was 
estimated using the same ratio of tissue to bulk diffusivities for oxygen and glucose (-0.45). 
From the diffusion experiments, data was collected to determine the effective 
diffusivity as a function of the conduit porosity. Using equation 9, a plot of logarithm of the 
ratio of effective to bulk diffusivities versus the logarithm of porosity should give a straight 
line with a slope of l+b. Figure 10 shows this relationship for the diffusion of oxygen and 
glucose. The slopes are similar and therefore give the same power law exponent. The value 
determined from both experiments is 5.1. Since NGF is smaller than the pore size of the 
membrane, the value for the power law exponent is assumed to be the same. The diffusion 
parameters are summarized in Table 3. 
Because the salt crystals used in membrane formation had varying sizes, the resulting 
pores also varied in size. Figure 11 is an image of the pore structure of a membrane. The 
image shows the two sides of a membrane. A skin formed on the air-exposed side of the 
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Figure 10. Correlation of Porosity to Effective Diffusivity. From equation (9), plotting the 
log of the ratio of effective to bulk diffiisivities versus the log of porosity gives a straight line 
with a slope of 1+b (power law exponent). 
Table 3. Summary of Diffusion Parameters 
Dbulk Power Law ^imue 
(cm-/s) Exponent (cm'/s) 
Oxygen 3.0x10"^ 5.1 1.32x10' 
Glucose 9.1xl0-<' 5.1 3.6x10"^ 
NGF 5.3x10 ' * 5.1 * 2.4x10"' * 
* - Estimated 
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Figure 11. Light Microscopy Image of Membrane Surface. Pores of varying sizes are shown. 
Porosity = 0.93. Membrane thickness = 0.9 mm. Left-, air exposed side. Right: bottom side. 
Bar represents 100 |im. 
membrane that was less porous than the underlying structure. During the processing of the 
flat membranes, there was some settling of the salt crystals that remained on the bottom of 
the mold after removal of the membrane. Also, when pouring the polymer/salt suspension 
into the mold, some residual polymer remained in the vial. As a result, the final porosity was 
greater than the initial estimate in all cases. 
Kinetic Experiments 
The specific rates of nutrient uptake and NGF production were determined 
experimentally or estimated from literature values. Batch cultures of both Schwann cells and 
neurons were used to determine the consumption of nutrients. The uptake rates of oxygen and 
glucose were determined by performing a linear regression on the concentration data 
collected over time. For the oxygen uptake experiments, there was an apparent initial 
increase in concentration as the device became acclimated to the higher temperature of the 
incubator (Figure 12). During the glucose uptake rate experiments for the axons, there was 
no detectable change in the glucose concentration levels. 
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Figure 12. Oxygen Uptake by Schwann cells. The specific oxygen uptake rate was 
determined from the concentration change over time. An average of three experimental runs 
was used in the model. A slight apparent increase in concentration was seen as the 
experimental device became acclimated to incubator temperature. 
The effects of cell proliferation as well as neuron/Schwann cell interaction on the 
production of nerve growth factor by Schwann cells was examined. The cells were cultured 
for 48 hours and the medium was assayed for NGF content. After the experiment, cells were 
removed from the flasks and counted in order to estimate the specific growth rate of the 
Schwann cells. As expected, Schwann cells cultured with recombinant glial growth factor II 
had the highest growth rate. Yields were determined for each case and the overall production 
rate was calculated. Schwann cells cultured with only DMEM/10% PBS did not produce any 
significant amounts of NGF. The results for the production of NGF by Schwann cells gave a 
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rate that was much smaller than expected especially when compared to values obtained for 
NGF secreting fibroblasts (2.3x10 "° versus 2xlO '' mg/cell • s). Table 4 summarizes the 
results from the NGF production experiments. 
The consumption of nerve growth factor was examined to determine the rate law 
Table 4. Production of NGF by Schwann cells cultures under various conditions (n=3). 
Specific Growth NGF Yield NGF Production 
Rate (lO'^/hr) (pg/cell) Rate (pg/cell hr) 
DMEM/10%FBS 1.34 0 0 
w/rhGGF2 8.45 9.66x10"^ 8.16x10® 
w/deg. nerve 2.61 5.58x10 ® 1.46x10"® 
w/cond. med. 1.99 8.06x10"® 1.60x10"® 
constant, kp, from the dual receptor model for NGF uptake (equation 2). Samples were taken 
daily and assayed for NGF content using an ELISA. The volume was measured to take into 
account loss of fluid due to sampling and evaporation. Fitting the model to the experimental 
data gave a value for kp of 0.0084 /s. Only the data from the first 75 hours was used because, 
at longer times, the amount of NGF was below the detectable level of the ELISA (~ 10 
pg/ml). Figure 13 shows the fit of the model to the experimental data. 
For the axon experiments, the number of neurons was determined by image analysis. 
Figure 14 is an example of an image used for the cell count. Because it is difficult to separate 
the Schwann cells from the dorsal root ganglia, the consumption rates are not for neurons 
alone but also include the Schwann cells associated with the neurons. This assumption is 
practical since Schwann cells are present in the sciatic nerve which will be used for testing 
the conduit. The results of the batch culture kinetic experiments are summarized in Table 5. 
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Figure 13. Consumption of NGF by dorsal root ganglia. Experimental data is used to 
determine rate law constant for the dual receptor model. 
Figure 14. Image used for Neuron Counts. Neurons were stained with NeuroTag Red and 
visualized under fluorescence. Images were analyzed to determine number of neurons within 
a certain area. 
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Table 5. Summary of Kinetic Parameters (n=4) 
Schwann Cells Axons 
(mg /cell •s) (mg /axon "s) 
Oxygen 1.3x10'- 1.27x10' 
Glucose 7.8x10-'^ 5.6x10' 
NGF 2.3x10-2° kp = 0.0084 s' 
Other Parameters 
Besides the kinetic and diffusion constants, other parameters are needed for the 
model. The number of axons is estimated from that found in the rat sciatic nerve. The rat 
sciatic nerve contains approximately 1000 axons and is about 1 mm in diameter. This gives 
an axon density of 31800 axons/cm". The Schwann cell density was determined assuming 
the cells form a monolayer on the surface of the polymer within the pores. For mathematical 
purposes, the pores were assumed to be straight and cylindrical with a constant radius. The 
Schwann cell density is then 10^ x porosity. For diffusion in the bulk, a mass transfer 
coefficient was incorporated into the model. For in vitro experiments, film resistance is 
considered negligible so a large mass transfer coefficient was used (10000 cm/s). The value 
can be altered to account for diffusion through surrounding tissue. 
Model Results 
The aforementioned parameters were incorporated into a FORTRAN computer 
program to solve equation (1) for each component and each layer (See Appendix A for code). 
Concentration profiles were determined for NGF and oxygen for various porosities, wall 
thicknesses, and Schwann cell layer thicknesses. These parameters were chosen since they 
can be controlled when producing the bioartificial nerve graft and also, because they 
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determine tiie mass transport within the system. Values for the conduit dimensions, porosity 
and inner and outer diameters were chosen based on values given for other artificial nerve 
grafts. Schwann cells were assumed to either form a monolayer or to only slightly penetrate 
into the conduit wall (up to O.I mm). Figures 15, 16, and 17 show the dependence of the 
concentration profiles on porosity, wall thickness, and Schwann cell layer thickness, 
respectively. The parameters that lead to greater NGF concentrations, low porosity, greater 
wall thickness and Schwann cell layer thickness, also lead to a decrease in the amount of 
oxygen available to the axons. These conditions, however, did not have a significant effect 
on the concentration profiles for glucose (not shown). 
Neuron Extension Rates 
The model was used to optimize the conditions of the bioartificial nerve graft that result in 
an increase in the growth rate of the axons. Since the model only determines the 
concentration of nerve growth factor, the relationship between NGF and axon growth had to 
be evaluated. Neurons were cultured on different substrates with varying NGF 
concentrations to determine the effect of the substrate on the NGF promoted growth. The 
results are summarized in Figure 18. Images were obtained over time and then analyzed to 
determine the lengths of the axons. Example images used in determining axon lengths are 
shown in Figure 19. Linear regressions were performed on the axon length and time data to 
determine the extension rate of the axons. No differences were seen in neurons grown on 
fibrin compared to the control group. Though axons cultured on a layer of Schwann cells 
grew significantly faster than those cultured on fibrin and the control group, severe branching 
was noted in all cases. 
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Figure 15. Concentration Profiles as a Function of Conduit Porosity (e). At lower porosities, 
NGF concentration increases but oxygen becomes limiting. 
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Figure 16. Concentration Profiles as a Function of Wall Thickness. Larger wall thickness 
provides greater strength and further concentrates NGF within the lumen. Oxygen supply 
becomes limiting. 
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Figure 17. Concentration profiles with respect to Schwann Cell Layer Thickness. More 
Schwann cells will supply more NGF to the growing axons but will also consume more of 
the nutrients that may be needed by the axons. 
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Figure 18. Effect of NGF on Axon Extension Rate. Neurons were cultured on both laminin 
and BSA coated dishes. The extension rate approaches a maximum limit for NGF 
concentration greater than 10 ng/ml. A local maximum also occurs near 0.01 ng/ml. 
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Figure 19: Sample Images of Neurons Grown on Various Substrata. A) Fibrin Substrate. Day 
0. 400x. B) Fibrin Substrate. Day 6. 200x. C) Schwann Cell Substrate. Day 3. lOOx. D) 
Schwann Cell Substrate. Day 7.4Gx. 
Conduit Experiments 
The effects of porosity, wall thickness, and preseeded Schwann cell density were 
examined using conduits that were prepared as described earlier. Scanning electron 
micrographs of preseeded conduits are shown in Figure 20. Conduits not preseeded with 
Schwann cells were prepared as a control. The list of conduits with individual physical 
parameters is shown in Appendix D. Fibrin did not form sufficient support structure within 
lumen. Axons extended from the DRG to the lumen surface. Schwann cells migrated into 
pores of the conduit though some formed a cable within the lumen. Extracellular matrix can 
be seen covering the surface of the lumen and spreading into the pores. 
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Figure 20. Sample Scanning electron micrographs of conduits preseeded with Schwann cells. 
Left: Axons are observed extending from dorsal root ganglion. Matrix layer forms on the 
inner lumen surface. Right: Schwann cells form cable that supports axon growth. 
Cross sections of the conduit were obtained every 200 jim from dorsal root ganglia. 
Images were obtained for the sections containing neurons and analyzed on a computer. 
Examples of the sections are shown in Figure 21. The maximum length of the axons was 
estimated based on the last slice to contain neurons. The effects of Schwann cell seeding 
density, wall thickness, and porosity on the axon extension are shown in Figures 22, 23, 24, 
respectively. In virtually all cases, the conduits seeded with Schwann cells significantly 
enhanced growth compared to the non-preseeded ones. Enhancement due to Schwann cells 
was only significant when the seeding density was greater than 10® cells/ml (Figure 22). For 
densities less than that, no differences were seen between preseeded and non-preseeded 
conduits. Axon growth is significantly reduced in conduits with wall thicknesses greater than 
0.81 mm (Figure 23). This effect was observed in both preseeded and control groups. A 
slight increase in growth with increasing porosity was observed in the control groups but was 
determined not to be statistically significant (Figure 24). In the preseeded conduits, a 
significant increase in growth was observed at a porosity of 0.75 compared to porosities at 
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Figure 21. Sample images of sections obtained from conduit with porosity of 0.79, wall 
thickness of 1.44 mm, and Schwann cell seeding density of IxlO' cells/ml. Upper Left: DRG 
shown in conduit lumen. Upper Right: Section at 400^m. Lower Left: Section at 800^m. 
Axons grow on lumen surface. Lower Right: Section at 1200nm. No axons are present. 
Large undissolved sections of polymer are seen in lumen. 
0.65 and 0.85. The nonporous conduits had much lower growth when compared to the 
porous ones. 
Branching of axons within the conduit can be evaluated using image analysis. As the 
axons extend down the length of the conduit, an increase in the axon counts may be 
indicative of branching. An increase in axon counts along the conduits was only observed at 
higher Schwann cell seeding densities. Figure 25 is an example of the appearance of 
branching. The relative numbers of axons are plotted against a dimensionless length to 
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Figure 22. The Effect of Schwann Cell Seeding Density on Axon Growth in a Bioartificial 
Nerve Graft. Conduits have an average wall thickness of 0.85 mm and porosity of 0.75 
(n=3). 
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Figure 23. The Effect of Wall Thickness on Axon Growth in a Bioartificial Nerve Graft. 
Conduits preseeded with lO' Schwann cells/ml and have a porosity of 0.75 (n=3). 
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Figure 24. The Effect of Porosity on Axon growth in a Bioartificial Nerve Graft. Conduits 
preseeded with 10^ Schwann ceils/ml and have an average wall thickness of 0.67 mm (n=3) 
compare the effect of Schwann cell seeding density on branching. Without branching. The 
number of axons should remain fairly constant and than decrease near the end of the axon 
bundle. The decrease would be due to the varying growth rates of the individual axons. An 
increase in axon numbers is only observed at a cell • 
density of 10'cells/ml. 
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Figure 25. The Effect of Schwann Cell Seeding Density on Axon Branching. Axon 
numbers were determined relative to initial count. Dimensionless length describes the 
distance as a fraction of total length. 10^ cells/ml conduit has porosity of 0.75 and wall 
thickness of 0.78 mm. 10^ cells/ml conduit has porosity of 0.75 and wall thickness of 0.82 
mm. 
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DISCUSSION 
To aid in the design of the bioartificial nerve graft, a computer model was developed 
to describe the kinetics and mass transfer occurring in the conduit. Experiments were 
completed to determine diffusion and kinetic parameters to be used in the model. The model 
can then be used to examining the effects of porosity, wall thickness, and Schwann cell 
density on the design of the bioartificial nerve graft. Conduits were made from poly-D,L-
lactide with varying porosities and wall thicknesses to determine the efficacy of the computer 
model. 
For the diffusion parameters, porous membranes were first formed from poly-D,L-
lactide. The membrane was placed in a diffusion apparatus and the diffusion of oxygen and 
glucose through the membrane was evaluated. The formation of the porous membrane by 
dissolution of salt crystals from the polymer is similar to the formation of certain catalysts 
that are considered to be fractal in structure [67]. A fractal model can describe the pore 
diffusion through such membranes. Results from the diffusion experiments for oxygen and 
glucose are consistent with respect to the power law exponent. This validates the use of this 
fractal model to describe diffusion though the porous membrane and can be used to describe 
pore diffusion in the conduit provided that the conduit is manufactured in a similar manner. 
Because the exponent value was the same for both oxygen and glucose, the ratio of 
effective to bulk diffusivities is a function of the pore structure. Also, the ratio is independent 
of the size of the chemical species provided that there are no charge effects and that the 
chemical species is much smaller than the pore diameter. The value of the power law 
exponent for nerve growth factor is assumed to be the same because the size of 7S-NGF is 
much smaller than the pore size (-8x10"^ vs 100 ^m) and therefore any wall effects can be 
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neglected [71]. 
The Schwann cell and axon layers are the only regions where chemical reaction 
occurs. Oxygen and glucose are consumed in both layers while nerve growth factor, on the 
other hand, is produced by the Schwann cells and consumed by the axons by endocytosis. 
The consumption rates of oxygen and glucose by Schwann cells are consistent with the 
values found for other mammalian cells. 
With the diffusion and kinetic parameters determined or estimated, the model can 
then be used to examine the effects of porosity, wall thickness and Schwann cell layer 
thickness on the concentrations of NGF and nutrients. Glucose was found not to be a 
limiting nutrient. This was expected since the glucose consumption experiments did not 
show much of a change in the concentration over time. Compared to glucose, oxygen levels 
dropped more significantly in the kinetic experiments. Cells began to detach and die when 
the oxygen levels dropped below 2.0 |ig/ml. As a result, this limit was set as the minimum 
required oxygen concentration in the conduit center to ensure enough nutrients would be 
supplied to the axons. 
The effect of both porosity and wall thickness on the concentrations of nerve growth 
factor and oxygen was examined using the computer model. The Schwann cell layer 
thickness was kept constant at 0.1 mm. Figure 26 shows the centerline concentrations of 
NGF and oxygen as a function of porosity and wall thickness. The model shows that wall 
thickness and porosity can be varied to alter the NGF concentration but only up to the region 
where oxygen becomes limiting. At the point where oxygen becomes limiting, the 
concentration of NGF is constant (4 pg/ml). 
The effect of exogenous nerve growth factor on the extension rate of axons is 
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insignificant when compared to the influence of Schwann cells (Figure 18). For neurons 
cultured with Schwann cells, a local maximum in the extension rate is observed at a nerve 
growth factor concentration of 0.01 ng/ml. This maximum effect has also been observed 
using dorsal root ganglia cultured on mats of flbronectin but at a maximum of 3 ng/ml [72]. 
The differences in the NGF concentration may be due to the influence of other growth factors 
produced by Schwann cells on the extension of the axons. The authors assumed that the 
observed decline was due to some toxic effect from the NGF. The range of values they 
considered was from 0-10 ng/ml. Several other researchers have reported enhanced 
extension at substantially higher concentrations of NGF in agreement with results shown in 
Figure 18 [73],[13],[11]. 
The cause of this effect is unclear but may be related to the low affinity receptor 
p^gNGFR gjgQ found in Schwann cells. The purpose of this is unknown but it may aid 
in the transfer of NGF from the Schwann cells to the axons [74] or it may be part of a 
feedback mechanism to reduce the production of nerve growth factor [75]. Such a 
mechanism may influence the production of other growth factors that affect regeneration, 
especially brain-derived neurotrophic factor. p75''°'^ also has an affinity for these growth 
factors [17]. At low exogenous NGF concentrations, all of these factors are being produced 
at a normal rate. As more NGF is added, the production of these factors decreases and nerve 
growth becomes dependent only on the concentration of exogenous nerve growth factor. 
The graft needs to be designed to ensure a sufficient supply of oxygen is available to 
the cells before the graft is vascularized. Using a diilusion-reaction model of nerve 
regeneration, Podhajsky and Myers determined that the formation of vasculature may be the 
rate limiting step in nerve regeneration [76]. The relationship between nerve regeneration 
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and vasculature formation is not known since neovascularization was shown to depend on the 
degree of nerve regeneration [77] while axon growth was also shown to be limited by the rate 
of vascularization [78]. The limitation of the vascularization may be overcome by changing 
the porosity and wall thickness to ensure that enough oxygen reaches regenerating axons. 
Nutrients diffusing from existing vasculature may allow the axons to grow until new 
capillaries can infiltrate the nerve graft. 
The extension of axons through the conduit will be enhanced by the use of Schwann 
cells, by both contact with the axons as well as by the production of nerve growth factor. 
Nerve growth factor has long been known to be a potent promoter of nerve growth [11]. 
Following injury, there is a substantial increase in the production of NGF as shown by the 
increased levels of NGF-mRNA in Schwann cells and fibroblasts [8]. Interleukin-1 (IL-1), 
produced by activated macrophages found at the injury site, has been shown to mediate the 
increased levels of NGF-mRNA in fibroblasts but not in Schwann cells [79]. Although 
research has shown that Schwann cells produce NGF at a higher rate due to contact by 
neurons or by stimulation from other chemical factors such as PDGF or bFGF, the exact 
production rate has not been determined. The current model does not take into account NGF 
that may be produced by Schwann cells in the distal segment of the nerve. 
The purpose of this conduit is not to maximize the concentration of NGF within the 
lumen but rather to provide sufficient NGF to maximize the axon extension while allowing 
an adequate supply of nutrients to reach the axons. The axon extension rate experiments 
show the effect of NGF concentration on growth of the axons (Figure 18). Torigoe and 
coworkers have shown that sciatic nerve axons have two different growth phases in vivo [80]. 
Their work shows that axons grow at a slower rate (77 ^ m/day) during the first three days 
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when compared to days 3-6 (283 ^m/day). The results from Figure 18 show growth rates are 
consistent with the rates obtained by Torigoe and coworkers for axons during the initial slow 
growth phase. In their experiments, axons were regenerating in proximity with Schwann 
cells and fibroblasts and the physical contact may have further enhanced the growth rate. 
Schwann cells in contact with neurons produce NGF at a greater rate than when not in 
contact. Since the level of NGF that the neurons experienced in vivo is unknown, the 
observed extension rates may be due to a high concentration of NGF, physical contact or 
both. 
Nerve growth factor produced by the distal segment may have had a neurotropic 
effect that assisted in the guidance of the growth cone especially in the fast growth rate phase 
seen by Torigoe and coworkers. Also, successful regeneration will not occur without the 
presence of the distal segment [35]. This neurotropic effect can explain the enhancement of 
regeneration seen in silicone conduits with proximal segments placed at both ends [81]. 
Growth cones sense this gradient and will grow toward the distal stump [20]. As shown in 
Figure 19d, for axons growing in contact with Schwann cells, the lack of a distal segment 
decreases the growth cones ability to detect environmental cues which will lead to more 
random motion as well as branching on the axon. 
The effect of Schwann cell density on branching was observed in axons grown in two-
and three-dimensional environments. Measurements at various cross sections in the 
bioartificial nerve graft show an increase in axon numbers away from the initial point (Figure 
25). Figure 27 shows a sample image from the axon extension rate experiments. The small 
number of Schwann cells was due to the dorsal root ganglia digestion. Axon growth appears 
to be more directed toward the Schwann cells and less branching occurs especially when 
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Figure 27. Axon extension on Fibrin Substrate with low Schwann Cell density. Axon 
growth is directed toward Schwann cells and less branching occurs. Day 2 of culture. 
Magnification 200x. 
compared to axon growth seen in Figure 19d. At lower Schwann cell densities, growth cones 
would be able to detect gradients of neurotrophic and enhance axon growth by the neurotropic 
mechanism. Because growth cones extend several lamellapodia to detect these environmental 
cues, increased Schwann cell densities may cause the growth cones to split and move in 
different directions thus leading to increased branching. Branching that occurs within the 
conduit may not actually be branching but instead may be doubling back of fast growing 
axons. Either result can lead to painful neuroma formation and needs to be reduced. 
Though NGF alone enhances growth, the formation of a gradient may also improve 
regeneration by causing the growth cones to extend in the correct direction. Studies have 
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shown that the addition of nerve growth factor to artificial nerve grafts can greatly enhance 
the regeneration of peripheral nerve [51],[82]. Nonporous artificial nerve grafts also enhance 
regeneration by concentrating chemical factors, such as NGF within the lumen of the conduit 
[47]. In these cases, a gradient of NGF does not exist along the length of the conduit. Axon 
extension is increased by the mere presence of NGF. 
A gradient of NGF can be formed within the lumen of a porous conduit. NGF 
produced by the distal stump will diffuse towards the proximal end but some will be lost 
through the pores. Previous studies are inconclusive about whether or not this phenomenon 
occurs since most work just includes the use of one type of conduit and does not consider the 
effect of porosity on nerve regeneration. 
The model can be used to explain trends in the experimental data. The number of 
axons determined in the initial section of the conduit was used to calculate the axon density. 
For modeling purposes, the axons were assumed to be evenly distributed within the lumen of 
the conduit. In conduits preseeded with Schwann cells, however, the cells were observed to 
be distributed within the pores of the conduit suggesting that the fibrin matrix did not provide 
a sufficient support within the lumen of the conduit. Table 6 lists the parameters used in the 
model to compare with the experiment data. Model predictions for centerline oxygen and 
nerve growth factor concentrations are plotted with axon lengths, mean axon diameter, and 
total axon numbers from experimental results in Figures 28,29, and 30. Diameters and axon 
numbers were measured approximately 400 ^m from the dorsal root ganglia. 
The computer model predictions for nerve growth factor and oxygen concentrations 
can explain significant differences in axon growth for various conditions. Because of 
resistance to mass transfer, increasing the wall thickness and decreasing porosity leads to a 
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Table 6. Model parameters used to compare with experimetital results. 
Cases Base Porosity 
Wall 
Thicicness Cell Density 
Porosity 0.79 0.48 0.37 0.79 
Inner Diameter, mm 1.2 1.2 1.2 1.2 
Outer Diameter, mm 2.8 2.4 4.1 2.8 
Axon Density, axons/cm" 14900 16100 16300 28600 
Schwann Cell Density, cells/ml 2.3x10® 3.3x10® 9.4x10' 2.3x10^ 
Length, jim 
Oj, |ag/mi 
NGF, pg/ml &0 
S 2000 
1.5 o 
m. 
p„ = 2 JxlO* 6 = 0^5 AR = 1.4 mm p„ = 2JxlO^ 
AR = 0.82mm 
s = 0.75 
Figure 28. Comparison of Model Predictions for O2 and NGF Concentrations to 
Experimentally Determined Axon Lengths. 
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Figure 30. Comparison of Model Predictions for O2 and NGF Concentrations to 
Experimentally Determined Axon Diameters. 
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decrease in oxygen and an increase in NGF available to the axons. Some growth still occurs 
due to the migration of the axons to the lumen surface as seen in Figures 20 and 21. 
Decreases observed in growth for axons at lower porosities and larger wall thicknesses can be 
attributed to the drop in oxygen concentrations below the 2 ^ig/ml limit (Figure 28). This 
effect is shown for both preseeded and control conduits. Decreasing porosity and increasing 
wall thickness lead to the retention of more growth factors within the lumen of the conduit 
which can enhance the survivability of the neurons. This effect is seen by the increase in 
axon numbers and mean diameter as shown in Figures 29 and 30 for the cases of decreased 
porosity and increased wall thickness. The model cannot explain the increase in axon counts 
and mean diameter for the case of decreased cell density. 
Porosity is of greater importance in the design of the bioartificial nerve graft. 
Increased porosity leads to enhanced oxygenation of the axons but allow for increased 
diffusion of neurotrophic factors out of the conduit. Guenard, et al have developed a highly 
porous conduit with an inner layer that has a molecular weight cutoff of 50,000 [54]. Such a 
conduit would retain the larger growth factors while allowing sufficient oxygen diffusion. 
From Figure 24, a maximum in the growth of axons occurs at a porosity of 75%. A higher 
porosity leads to a loss of neurotrophic factors from the lumen thus decreasing growth. 
Table 7 compares bioartificial nerve grafts developed by various researchers. Other 
than the brief discussion on the importance of porosity [59], not much consideration was 
given to the physical parameters of the conduit. The bioartificial should be designed to 
maximize growth across the gap. Once the axons cross the gap, they enter the endoneurial 
tubes and continue until functional recovery is achieved. At this point, the bioartificial nerve 
graft would not provide any more support than the distal segment would. Only Guenard, 
67 
Table 7. Comparison of various Bioartificial Nerve Graft Designs 
Conduit 
Material 
OD ID 
(mm) (mm) 
Gap 
(mm) 
Schwann 
Cells 
Growth 
Rate 
Guenard PAN/ 1.37 1.12 ? 8 4-12E7 cells/ml 381 ^m/day 
(1992) PVC Matrigel in 
lumen 
Bryan PE 7 ? 0? 20 Lumen 370 (im/day 
(1996) monolayer 
Brown PGA 9 ? 0? 30 1-5E5 cells in 16 wks to 
(1996) lumen f.r. 
Ansselin Kevlar/ 1 9 0? 20 o5E5 cells in 20-30 wks 
(1997) Collagen lumen to f.r. 
Hadlock PLLA/ 2.0 1.8 0 20 Lumen 12 wks to 
(1998) PLGA monolayer f.r. 
Rutkowski PDLLA 2.8 1.2 0.75 10 2.3E6 cells/ml in 118 ^m/day 
& Heath wall 
(1999) 
Bryan, and Rutkowski, report values for the extension rate through the graft. The higher 
values reported by Guenard and Bryan may due to the examination of nerve regeneration in 
vivo compared to cultures incorporating dorsal root ganglia in vitro. In several cases, the 
Schwann cells formed a monolayer on the inner lumen surface. More Schwann cells can be 
placed in the conduit by suspending them in a gel within the lumen or by allowing the cells to 
migrate and adhere to surfaces with the pores. Because of increased surface area, more 
Schwann cells can adhere to surfaces in a porous conduit compared to a nonporous one. One 
major drawback to seeding Schwann cells into the conduit pores is the reduction of Schwann 
cell/neuron contact that can further enhance regeneration. Seeding more Schwann ceils into 
the pores of the conduit will increase the concentration of growth factors in the lumen of the 
conduit which can further enhance the growth of the axons. The Schwann cells would still be 
able to migrate into the lumen to contact the growing axons and further stimulate growth as 
well as remyelinate them. 
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The computer model predicts a nerve growth factor concentration of 0.6 pg/ml for the 
base case. At this concentration of NGF, Figure 18 shows that the extension rate should fall 
between 0 |im/day for axons growing on fibrin and 65 nm/day for axons on a confluent 
monolayer of Schwann cells. Since the growth rate was 118 ^m/day for this case, the 
differences in growth is due to some other mechanism. Branching of axons within the 
conduits led to an approximate doubling in the total number of axons (Figure 25). Axons 
cultured with Schwann cells appear to have more severe branching (Figure 19d). Neurons 
can extend axons a greater distance when there is less branching since energy would not be 
expended to the growth of multiple branches. Though seeded with a high Schwann cell 
density, axons within the conduit may not be in contact with as many cells compared to axons 
cultured on a Schwann cell monolayer which would result in decreased branching. The 
lumen of the conduit can enhance growth by keeping the axons aligned and guiding growth in 
one direction. 
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CONCLUSIONS 
The design of the bioartificial nerve graft presented in this study enhances the rate of 
peripheral nerve growth. The inclusion of Schwann cells within the pores of the conduit 
enhances the growth of the axons by physical contact and by the production of nerve growth 
factor. A porous conduit will also aid in the diffusion of nutrients to cells within the lumen 
of the conduit. This will allow the cells to survive until the formation of neo vasculature 
through the pores of the conduit. 
Axons in contact with Schwann cells grow at a higher rate compared to those that are 
not in contact due to neurotrophism. A large Schwann cell concentration can mask 
environmental cues that guide growth cone motion. Without these cues, growth cones have a 
random motion that can also lead to severe branching of the axon. Though less growth 
factors would be produced, a decrease in the number of Schwann cells can enhance axon 
extension through the reduction of branching as well as by neurotropism, the formation of 
concentration gradient. 
The computer model is important in determining appropriate porosity, wall thickness, 
and cell density that will maximize axon growth while ensuring an adequate supply of 
nutrients. When the model predicts oxygen concentrations below the level at which it 
becomes limiting, axon growth is hindered. Lower porosity and greater wall thickness lead to 
situations where oxygen may become limiting despite increasing the amount of NGF 
concentrated within the lumen. 
Many factors must be considered when creating a bioartificial nerve graft. The 
conduit must be biocompatible and ideally should be bioresorbable to prevent the need for a 
second surgery. Making the conduit porous will allow nutrients to be supplied to the 
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Schwann cells and axons. A larger wall thickness may provide stability and greater 
protection for the nerve but fewer nutrients can be supplied to the lumen. The computer 
model can be used to maximize the amount of NGF and other growth factors available to the 
growing axons while determining if oxygen may be limiting. Maximizing the growth rate of 
the axons through the conduit increases the chance that the axons will be able to reach their 
target thus leading to full recovery. 
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APPENDIX A. COMPUTER PROGRAM 
* Artificial Nerve Graft w/NGFR kinetics 
* .. Parameters.. 
INTEGER NOUT 
PARAMETER (NOUT= 11) 
INTEGER NEQ, LENWRK, METHOD 
PARAMETER (NEQ=6,LENWRK=32*NEQ,METHOD= i) 
DOUBLE PRECISION ZERO, ONE, TWO 
PARAMETER (ZERO=O.ODO,ONE= 1.0D0,TWO=2.0D0) 
CHARACTER *8 OUTPUT 
* .. Local Scalars .. 
DOUBLE PRECISION HNEXT, HSTART, PI, TEND, TGOT, TINC, TOL, TSTART, 
+ TWANT, WASTE,KL, KH, LO, HO, KP, PROD 
INTEGER I, IFAIL, J, L, NPTS, STPCST, STPSOK, TOTF, Q,N 
LOGICAL ERRASS 
* .. Local Arrays .. 
DOUBLE PRECISION THRES(NEQ), WORK(LENWRK), YGOT(NEQ), 
YMAX(NEQ), 
+ YPGOT(NEQ), YSTART(NEQ), R(3,5), D(3,5), C(3) 
DOUBLE PRECISION K(3), YINIT(3), P, PCOEF, DBULK(3), CELLDENS, 
+ CELLS, RAD(4), LENGTH, CELLVOL,AXONS, AXONDENS 
DOUBLE PRECISION AREA 
REAL YBULK(3), YBOLD(3) 
* External subroutines used to solve differential equations 
EXTERNAL D02PCF, D02PVF, D02PYF, F1, F3, F4 
* .. Executable Statements .. 
WRITE (6,*) 'Artificial Nerve Graft Simulation' 
* Set Constants for main Program 
* 
* Variables 
* Open data file that contains variables such as wall thickness, porosity 
* and Schwann cell layer thickness. Variables are written to the screen. 
OPEN (12,FILE='data.dat',ACCESS=DIRECT',RECL=9,FORM= FORMATTED') 
WRITE (6,*) 'File opened' 
DO I Q=l,4 
READ (12,'(F8.7)',REC=Q) RAD(Q) 
WRITE (6,*) RAD(Q) 
1 CONTINUE 
READ (12,'(F8.7)',REC=5) P 
WRITE (6,*) 'Porosity Read' 
READ (12,'(A8)',REC=6) OUTPUT 
WRITE (6,*) OUTPUT 
READ (12,'(E8.2)',REC=7) KP 
WRITE (6,'(E8.2)') KP 
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READ (12,'(E8.2)',REC=8) YINIT(3) 
READ (12,'(E8.2)',REC=9) PROD 
CLOSE (12) 
Tube Parameters 
PCOEF is power law exponent for pore diffusion model 
Cell densities in units of cells/ml 
PCOEF = 5.1 
CELLDENS = P*lE+8 
AXONS = 31800 
Bulk Diffusivities(cm2/s) 
DBULK(l) = 3.0e-5 
DBULK(2) = 9.0918E-6 
DBULK(3) = 5.3E-7 
Reaction Rates(mg/ml s) 
R(layer,component) 
Components: Glucose( 1). oxygen(2), NGF(3) 
Layers: Axons(l), Perineurial Space(2), Schwann(3), Conduit(4) 
R(l,l)= 1.27E-9* AXONS 
R(l,2) = 0 
R( 1,3) = 1.3E-12*CELLDENS 
R(l,4) = 0 
R(2,I) = 5.6E-9*AXONS 
R(2,2) = 0 
R(2,3) = 7.8E-12*CELLDENS 
R(2,4) = 0 
R(3,l)= le-10*AXONS 
R(3,2) = 0 
R(3,3) = -PROD*CELLDENS 
R(3,4) = 0 
Diffusivities 
D(Component, Layer) 
D(1,1) = DBULK(1)*.44 
D(1,2) = DBULK(1) 
D(1,3) = DBULK(1)*.44 
D( 1,4) = DBULK( 1 )*P**( 1+PCOEF) 
D(2,1) = DBULK(2)*.4 
D(2,2) = DBULK(2) 
D(2,3) = DBULK(2)*.4 
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D(2,4) = DBULK(2)*P**(1+PC0EF) 
D(3,1) = DBULK(3)*.45 
D(3,2) = DBULK(3) 
D(3,3) = DBULK(3)*.45 
D(3,4) = DBULK(3)*P**(l+PCOEF) 
* 
* Mass Transfer Coefficient 
K(l)= 100000 
K(2) = 100000 
K(3) =-100000 
• 
* Receptor parameters 
KL= lE-9 
KH= lE-ll 
H0 = 2.21E-8 
L0= 1.90E-7 
* 
* Bulk Concentrations 
C(l) = 6.92E-3 
C(2) = 4.5 
C(3) = 0.0 
YBOLD(1) = C(1)/10 
YBOLD(2) = C(2)/10 
YB0LD(3) = 0.0 
* Region I - Axon Layer 
* Initial estimate of center concentrations 
* 
YINIT(l) = 0.3»C(l) 
YINIT(2) = 0.3*C(2) 
* YINIT(3) = 0.9*C(3) 
DO 75Q= 1,3 
* 
* Open File 
• 
5 OPEN (NOUT, FILE=OUTPUT) 
WRITE (NOUT,'(/A,F4.2)')' P =', P 
WRITE (NOUT,'(/A,D8.1)') 'Kp =', KP 
TSTART = 0.00000000000001 
YSTART(l) = YINIT(l) 
YSTART(2) = ZERO 
YSTART(3) = YINIT(2) 
YSTART(4) = ZERO 
YSTART(5) = YINIT(3) 
YSTART(6) = ZERO 
TEND = RAD(1) 
DO 10L= 1,NEQ 
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THRES(L) = l.OD-8 
10 CONTINUE 
ERRASS = .FALSE. 
HSTART = ZERO 
NPTS = 20 
TINC = (TEND-TSTART)/NPTS 
TOL= l.OD-3 
IFAIL = 0 
CALL D02PVF(NEQ,TST ART, YSTART,TEND,TOL,THRES,METHOD, 
+ "Usual Task',ERRASS,HSTART,WORK,LENWRK,IFAIL) 
WRITE (N0UT,'(/A,D8.1)') "Calculation with TOL =", TOL 
WRITE (NOUT, 11) "Radius ",'02 Cone"," Flux","Glucose", 
+ " Flux"," NGF," Flux" 
11 FORMAT (/, 1X,A9,T14,A9,T28,A9,T44,A9,T58,A9,T72,A9,T86,A9) 
WRITE (N0UT,"(1X,F9.6,6(3X,E12.6))") TSTART, 
+ (YSTART(L),L=1,NEQ) 
DO 12J = NPTS- 1,0,-1 
TWANT = TEND - J*TINC 
IFAIL= 1 
CALL D02PCF(FI ,TWANT,TGOT, YGOT, YPGOT, YMAX,WORK,IFAIL) 
WRITE (NOUT,'(IX,F9.6,6(3X,E12.6))') TGOT, 
+ (YGOT(L),L=l,NEQ) 
12 CONTINUE 
IFAE. = 0 
CALLD02PYF(TOTF,STPCST,WASTE,STPSOK,HNEXT,IFAIL) 
Region HI - Schwann Cell Layer 
Continuity of boundary between layers 
Fluxes and concentrations are assumed equal 
TSTART = TGOT 
YSTART(l) = YGOT(l) 
YSTART(2) = D(1,1 )* YG0T(2)/D( 1,3) 
YSTART(3) = YGOT(3) 
YSTART(4) = D(2,l)*YGOT(4)/D(2,3) 
YSTART(5) = YG0T(5) 
YSTART(6) = D(3,l)*YGOT(6)/D(3,3) 
TEND = RAD(3) 
DO 30 L= l.NEQ 
THRES(L) = l.OD-8 
30 CONTINUE 
ERRASS = .FALSE. 
HSTART = ZERO 
NPTS = 20 
TINC = (TEND-TSTART)/NPTS 
TOL= l.OD-3 
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IFAE. = 0 
CALLD02PVF(NEQ,TSTART,YSTART,TEND,TOL,THRES,METHOD, 
+ Usual Task',ERRASS,HSTART,WORK,LENWRK,IFAIL) 
WRITE (N0UT,'(IX,F9.6,6(3X,E12.6))') TSTART, 
+ (YSTART(L),L=1,NEQ) 
D0 31 J = NPTS- 1,0,-1 
TWANT = TEND - J*TINC 
IFAIL= 1 
CALL D02PCF(F3 ,TWANT,TGOT, YGOT, YPGOT, YM AX, WORK,IFAIL) 
WRITE (N0UT,'(1X,F9.6,6(3X,E12.6))') TGOT, 
+ (YG0T(L),L=1,NEQ) 
31 CONTINUE 
IFAIL = 0 
CALLD02PYF(TOTF,STPCST,WASTE,STPSOK,HNEXT,IFAIL) 
* 
* Region VI - Conduit Wall 
• 
TSTART = TGOT 
YSTART(1) = YGOT(l) 
YSTART(2) = D(l,3)*YGOT(2)/D(l,4) 
YSTART(3) = YGOT(3) 
YSTART(4) = D(2,3)*YGOT(4)/D(2,4) 
YSTART(5) = YGOT(5) 
YSTART(6) = D(3,3)*YGOT(6)/D(3,4) 
TEND = RAD(4) 
D0 40L= 1,NEQ 
THRES(L) = l.OD-8 
40 CONTINU'E 
ERRASS = .FALSE. 
HSTART = ZERO 
NPTS = 20 
TINC = (TEND-TSTART)/NPTS 
TOL= l.OD-3 
IFAIL = 0 
CALLD02PVF(NEQ,TSTART,YSTART,TEND,TOL,THRES,METHOD, 
+ Usual Task ,ERRASS,HSTART,WORK,LENWRK,IFAIL) 
WRITE (NOUT,'(lX,F9.6,6(3X,E12.6))') TSTART, 
+ (YSTART(L),L=1,NEQ) 
D0 41 J = NPTS- 1,0,-1 
TWANT = TEND - J*TINC 
IFAIL= 1 
CALL D02PCF(F4,TWANT,TGOT,YGOT, YPGOT, YMAX,WORK,IFAIL) 
WRITE (N0UT,'(1X,F9.6,6(3X,E12.6))') TGOT, 
+ (YGOT(L),L=l,NEQ) 
41 CONTINUE 
IFAIL = 0 
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CALLD02PYF(TOTF,STPCST,WASTE,STPSOK,HNEXT,IFAIL) 
* 
* Comparison of calculated bulk concentrations to boundary condition. 
* If both do not compare, calculations are repeated with new center 
* concentration estimated. 
* 
YBOLD(Q) = YBULK(Q) 
YBULK(Q) = YGOT(2*Q-l)-D(Q,4)*YGOT(2*Q)/K(Q) 
WRITE(6,*) • BULK Cone = ',Q,YBULK(Q) 
IF (ABS(YBULK(Q)-YBOLD(Q)) .NE. 0.0) THEN 
YINIT(Q) = YINrr(Q)+(C(Q)-YBULK(Q)) 
CLOSE(NOUT) 
IF ((Q .EQ. 3.0) .AND. (N .EQ. 50)) THEN 
PAUSE 400 
N = 0 
END IF 
N = N+1 
GOTO 5 
END IF 
75 CONTINUE 
END 
• 
* Subroutines 
* Each subroutine includes constants and differential equations 
* necessary to describe that layer 
* 
* Axon Layer Subroutine 
* 
SUBROUTINE F1(T,Y,YP) 
* .. Scalar Arguments .. 
DOUBLE PRECISION T,R(5,5),D(5,5), Q, DBULK(3) 
DOUBLE PRECISION AXONDENS, AXONS, KH, KL, HO, LO, KP 
INTEGER I 
* .. Array Arguments .. 
DOUBLE PRECISION Y(*), YP(*),NGF 
* .. Executable Statements .. 
DBULK(l) = 3E-5 
DBULK(2) = 9.0918E-6 
DBULK(3) = 5.3E-7 
AXONS =31800 
KL= l.OE-9 
KH= l.OE-11 
H0 = 4.98E-18 
L0 = 7.47E-17 
OPEN (12,FILE=data.daf,ACCESS=T)IRECT',RECL=9,FORM=FORMATTED) 
READ (12,'(E8.2)',REC=7) KP 
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CLOSE (12) 
R(l,l)= I.27E-9*AXONS 
R(2,l) = 5.6E-9*AXONS 
D(1,1) = DBULK(1)*.44 
D(2,1) = DBULK(2)*.4 
D(3,1) = DBULK(3)*.45 
YP(1) = Y(2) 
YP(2) = R(l,l)/D(l,l)-(Y(2))n' 
YP(3) = Y(4) 
YP(4) = R(2,l)/D(2,l) - (Y(4))/r 
YP(5) = Y(6) 
NGF = Y(5)/140000 
R(3,l) = (KP*LO*HO*(AXONS**2)*Y(5)/((KH+NGF)*(KL+NGF))) 
YP(6) = R(3,I)/D(3,lHY(6))n' 
RETURN 
END 
Schwann Cell Layer Subroutine 
SUBROUTINE F3(T,Y,YP) 
.. Scalar Arguments.. 
DOUBLE PRECISION T,R(5,5),D(5,5),DBULK(3),P, PROD 
DOUBLE PRECISION CELLDENS 
INTEGER I 
.. Array Arguments .. 
DOUBLE PRECISION Y(*), YP(*) 
.. Executable Statements.. 
OPEN (12.FILE='data.daf,ACCESS="DIRECT',RECL=9,FORM='FORMATTED') 
READ (12,"(F8.7)',REC=5) P 
READ (12,'(E8.2)',REC=9) PROD 
CLOSE (12) 
DBULK(l) = 3E-5 
DBULK(2) = 9.0918E-6 
DBULK(3) = 5.3E-7 
CELLDENS = P*(lE+8) 
R(l,3)= 1.3E-12*CELLDENS 
R(2,3) = 7.8E-12*CELLDENS 
R(3,3) = -PROD»CELLDENS 
D(1,3) = DBULK(1)*.44 
D(2,3) = DBULK(2)*.45 
D(3,3) = DBULK(3)».4 
YP(1) = Y(2) 
YP(2) = R(l,3)/D(l,3) - (Y(2))/T 
YP(3) = Y(4) 
YP(4) = R(2,3)/D(2,3) - (Y(4))/T 
YP(5) = Y(6) 
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YP(6) = R(3,3)/D(3,3) - (Y(6))/T 
RETURN 
END 
* 
* Conduit Wall Subroutine 
* 
SUBROUTINE F4(T,Y,YP) 
* .. Scalar Arguments .. 
DOUBLE PRECISION T,R(5,5),D(5,5), P, PCOEF,DBULK(3) 
INTEGER I 
* .. Array Arguments .. 
DOUBLE PRECISION Y(*), YP(*) 
* .. Executable Statements .. 
DBULK(l) = 3E-5 
DBULK(2) = 9.0918E-6 
DBULK(3) = 5.3E-7 
OPEN (12,FILE='data.daf,ACCESS=DIRECT',RECL=9,FORM='FORMATTED') 
READ (12,'(E8.7)',REC=5) P 
CLOSE (12) 
PCOEF = 5.1 
DO 801= 1,3 
D(I,4) = DBULK(D*P**(I+PCOEF) 
R(I,4)=0 
80 CONTINUE 
YP(1) = Y(2) 
YP(2) = R(l,4)/D(l,4) - (Y(2))/T 
YP(3) = Y(4) 
YP(4) = R(2,4)/D(2,4) - (Y(4))/T 
YP(5) = Y(6) 
YP(6) = R(3,4)/D(3,4) - (Y(6))/T 
RETURN 
END 
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APPENDIX B. DERIVATION OF DIFFUSION EQUATIONS 
Membrane 
Two chambers of equal volume, Vchamber. are separated by a membrane of thickness, L, and 
porosity, e. The two chambers contain a solute in liquid with concentrations a(t) and b(t) for 
chambers A and B respectively. The concentration within the membrane, c(x,t), is assumed 
to have a linear profile. The chambers are well mixed so that the concentration at the 
membrane surface is equal to the bulk concentration. 
Membrane concentration profile: 
@x=0 c(0,t) = a(t) 
@x=L c(L,t) = b(t) 
for equation of a line y = mx + b 
b = y-intercept = c(0,t) = a(t) 
. c(0,t)-c(L.t) a(t)-b(t) 
m = slope = Ay/Ax = —IE— 
Therefore, 
b(t)-a(t) 
c(x,t)= x + a(t) 
c(x,t) = a(t)-(a(t)-b(t))-^ (1) 
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Mass balance around chamber A: 
Accumulation = Flux in - Flux out + generation 
da 
^chamber ~ ^ membrane^ A "0+0 (2) 
where: 
Amembnme ~ ETtR (cm ) 
R = membrane radius (cm) 
Flux N A = Dg (mg/cm"*s) (3) 
ax 
De = effective diffusivity (cmVs) 
from equation 1: 
0c b(t)-a(t) 
ax - L 
combining equations 3,4,5: 
da £7tR^De ^b-a 
dt ^chamber L 
Similarly, a mass balance around chamber B gives: 
db £7tR-De b-a da 
dt ^chamber L dt 
Initial conditions: 
a(0) = ao and b(0) = bo (7) 
Combining equations S and 6: 
db da d(b-a)_ 2e7tR^De(b-a) 
dt dt dt L^chamber 
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Separating the variables and integrating: 
d ( b - a ) _  r 
Jbo-ao Jo 
pdt 
where 
„ 2e7cR^De 
P = 
^^chamber 
Solving equation 8 gives: 
( b - a )  =  ( b o  - a o ) e x p ( - P t )  
(8) 
(9) 
The volume of the membrane is assumed to be much less than the chamber volume 
'membrane 
^chamber 
« 0 . I  
Therefore the mass in both chambers is constant over time. 
(a + b) = (ao + bo) 
Adding equation 9 and 10 gives: 
(10) 
b  =  ^ ( a o + b o ) - | { a o - b o ) e x p  2£7tR-De 
^^chamber ^ 
and 
a  =  7 ( a o + b o ) + ^ ( a o - b o ) e x p  2etcR^De ^t 
^ ^^chamber ^ 
82 
APPENDIX C. NGF CONSUMPTION RATE LAW 
Kh 
S + H ^ SH + L ki 
SHL 
S + L ^ SL + H *^2 
A simple chemical model has been developed to describe the uptake of nerve growth 
factor (S) by neurons. NGF can bind to two different receptor found on the cell surface of 
neurons, a high affinity receptor, trkA (H), and a low one, p75NGFR (L). NGF can bind to 
either one but when bound to both the entire complex (SHL) is taken into the cell by 
endocytosis. KH and KL are the equilibrium constants for the high and low affinity receptors 
respectively. The rate constants, kl and k2, describe the rate of binding to the second 
receptor and the complex is irreversibly taken into the cell. 
Equilibrium Constants; 
[S][L] 
K (2, 
" " [SHl ® 
The complex SHL is assumed to be taken into the cell by endocytosis immediately upon 
binding of both receptors to NGF. The formation of the complex determines the rate of 
uptake. 
Rate of SHL formation: 
v = ki[SH][L] + k2[SL][H] (3) 
The amount of receptor is assumed to be constant with new receptor being produced or 
recycled as some is taken in by endocytosis. 
L o = L + S L  ( 4 )  
H o  = H + S H  (5) 
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Assuming that the binding of NGF to receptors is in equilibrium, equations 1-S can be 
combined to form: 
v = k, fjsll 
UhJ 
r K H [ H „ l Y K j L j l  
^ K H  + ( S ) | k l + [ S ] ^  + k. K L > 
' K i . [ L o ] Y K H [ H O ]  
, K l + [ S ] | K H + 1 S 1 J  
After simplification, this equation becomes: 
k p l H o j L j s )  
V = 
( KH + [ S])(KL +[S]) 
(6) 
where. 
Values for constants were obtained for receptors in dorsal root ganglia [13]. 
KH= 10 " M 
KL= 10-^ M 
Ho = 3000 molecules/cell 
Lo = 45000 molecules/cell 
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APPENDIX D: ORDER OF MAGNITUDE ANALYSIS 
dC, 1 d ( dC, ) 
— = A7 K— 
d t  r  d r \  d r  
\ /- 4 / ! / 
Time dependent term Diffusion term Kinetic term 
Values used for analysis: 
r = 0.6 mm Lumen radius 
dr = 0.6 mm Change in radius over which concentration changes 
D(02) = 1.3E-5 cm"/s From Table 3 
D(NGF) = 2.4E-7 cm'/s From Table 3 
dC(02) = 1.3 ng/ml From steady state model 
dC(NGF) = 1.7E-4 pg/ml From steady state model 
R(02) = 4E-5 mg/ml s From Table 5 
R(NGF) = 1.3E-6 mg/ml s Using Eqn. 3 w/ S = 4 pg/ml and kp = 0.0084 /s 
dt = Length (1 cm)/extension rate (200 |im/day) 
= 50 days 
Table 8. Final Results of Order of Magnitude Analysis for Computer Model 
Units: mg/ml s Oxygen NGF 
Time term 3.0E-10 3.9E-20 
Kinetic term 4.0E-5 I.3E-15 
Diffusion term 1.7E-8 LIE-17 
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3200 
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3400 
600 
1600 
1600 
6600 
0 
1200 
1600 
1200 
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4000 
4800 
1600 
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1600 
1200 
600 
2000 
1400 
1200 
800 
800 
0 
400 
600 
600 
86 
ID 
(cm) 
OD 
(cm) 
Weight 
(g) 
Estimate 
Porosity 
Calculated 
Porosity 
Cell 
Density 
(cells/ml) 
1.16 2.84 0.01567 0.75 0.761 10^ 
1.16 2.84 0.01565 0.75 0.762 10^ 
1.16 2.84 0.01677 0.75 0.745 10^ 
1.16 2.84 0.01061 0.75 0.838 0 
1.16 2.84 0.01587 0.75 0.758 0 
1.16 2.84 0.01374 0.75 0.791 0 
1.16 2.84 0.01434 0.75 0.782 0 
1.23 2.79 0.01642 0.75 0.734 10" 
1.23 2.79 0.01411 0.75 0.771 10" 
1.23 2.79 0.00897 0.75 0.855 10" 
1.19 2.82 0.01388 0.75 0.783 0 
1.23 2.79 0.01360 0.75 0.780 0 
1.23 2.79 0.01452 0.75 0.765 0 
1.23 2.79 0.01534 0.75 0.751 0 
1.19 2.82 0.01325 0.75 0.792 10^ 
1.19 2.82 0.01145 0.75 0.821 lO' 
1.19 2.82 0.01522 0.75 0.762 10' 
1.23 2.79 0.01106 0.75 0.821 10" 
1.19 2.82 0.01259 0.75 0.803 0 
1.19 2.82 0.01261 0.75 0.802 0 
1.13 1.87 0.01347 0.75 0.381 lo' 
1.13 1.87 0.01307 0.75 0.399 10' 
1.13 1.87 0.01387 0.75 0.363 lo' 
1.13 1.87 0.01054 0.75 0.516 0 
1.13 1.87 0.01486 0.75 0.598 0 
1.13 1.87 0.01096 0.75 0.496 0 
1.23 2.59 0.00568 0.75 0.888 lo' 
1.23 2.59 0.00870 0.75 0.829 10' 
1.23 2.59 0.00495 0.75 0.903 10' 
1.23 2.59 0.00715 0.75 0.860 0 
1.23 2.59 0.00631 0.75 0.876 0 
1.23 2.59 0.00677 0.75 0.867 0 
1.16 3.35 0.01481 0.75 0.847 10' 
1.16 3.35 0.01997 0.75 0.794 10' 
1.16 3.35 0.01941 0.75 0.800 10' 
1.16 3.35 0.01900 0.75 0.804 0 
1.16 3.35 0.01670 0.75 0.827 0 
1.16 3.35 0.01716 0.75 0.823 0 
1.22 3.02 0.08203 0 0 10' 
1.22 3.02 0.11045 0 0 0 
1.22 3.02 0.06293 0 0 lo' 
1.22 3.02 0.10534 0 0 lo' 
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# Conduit ID (cm) 
OD 
(cm) 
Weight 
(g) 
Estimate 
Porosity 
Calculated 
Porosity 
Cell 
Density 
(cells/ml) 
Length 
(Hm) 
83 H2C 1.22 3.02 0.10681 0 0 0 0 
84 H4C 1.22 3.02 0.20031 0 0 0 200 
85 H l C  1.22 3.02 0.09490 0 0 0 1000 
86 H4 1.22 3.02 0.10734 0 0 lO"' 400 
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